PG.ProteinGroups,PG.Genes,short.name,GO,sub.cell,description,GO.ID,ConditionNorm_N40_N_2,ConditionNorm_N40_N_3,ConditionNorm_N40_N_4,ConditionNorm_N40_N_5,ConditionNorm_N41_T_1,ConditionNorm_N41_T_2,ConditionNorm_N41_T_3,ConditionNorm_N41_T_4,ConditionNorm_N41_T_5,MedianConditionNormN41N,MedianConditionNormN41T,logFC,AveExpr,t,P.Value,adj.P.Val,B,mass,neglog(adj.P.Val),TotalPeptidesOverallInGene,N41N_Undetected,N41T_Undetected,LysoAssociated,LiveAssociated,NES
Q96CX2,KCTD12,KCD12_HUMAN,cell junction [GO:0030054]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; protein homooligomerization [GO:0051260],"SUBCELLULAR LOCATION: Cell junction, synapse, presynaptic cell membrane. Cell junction, synapse, postsynaptic cell membrane {ECO:0000250}.",BTB/POZ domain-containing protein KCTD12 (Pfetin) (Predominantly fetal expressed T1 domain),GO:0003723; GO:0030054; GO:0042734; GO:0042802; GO:0045211; GO:0051260,0.313525883,0.322714795,0.335880693,0.333281719,0.168582349,0.172447963,0.183739998,0.179002227,0.189214065,0.33199936,0.179002227,-0.154204323,0.255699482,-31.57839886,4.42E-10,2.54E-08,13.87671524,"35,701",7.595618048,15,0,0,,1,1
O43396,TXNL1,TXNL1_HUMAN,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; disulfide oxidoreductase activity [GO:0015036]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; thioredoxin-disulfide reductase activity [GO:0004791]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]",SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19349277}. Nucleus {ECO:0000269|PubMed:19349277}. Note=At least 85% of the cellular TXNL1 is proteasome-associated.,Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein),GO:0000502; GO:0004791; GO:0005634; GO:0005737; GO:0005829; GO:0015035; GO:0015036; GO:0016671; GO:0034599; GO:0045454; GO:0047134,0.258853242,0.300353505,0.295211829,0.315161311,0.117535541,0.124380997,0.123608262,0.135701484,0.135697681,0.49593348,0.124380997,-0.366586762,0.310678174,-26.279103,2.06E-09,7.75E-08,12.22004562,"32,251",7.110607969,19,0,0,,1,1
Q8N126,CADM3,CADM3_HUMAN,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; adherens junction organization [GO:0034332]; cell recognition [GO:0008037]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; protein localization [GO:0008104],SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q99N28}; Single-pass type I membrane protein {ECO:0000250|UniProtKB:Q99N28}. Cell junction {ECO:0000250|UniProtKB:Q99N28}.,Cell adhesion molecule 3 (Brain immunoglobulin receptor) (Immunoglobulin superfamily member 4B) (IgSF4B) (Nectin-like protein 1) (NECL-1) (Synaptic cell adhesion molecule 3) (SynCAM3) (TSLC1-like protein 1) (TSLL1),GO:0005102; GO:0005886; GO:0005887; GO:0005911; GO:0005913; GO:0007156; GO:0007157; GO:0008037; GO:0008104; GO:0034332; GO:0042803; GO:0050839,1.339062535,1.425378483,1.262308283,1.478778988,0.120221807,0.264497133,0.121883454,0.208694473,0.068780669,1.397320037,0.121883454,-1.271659,0.792645007,-22.823651,6.70E-09,1.78E-07,10.94034911,"43,300",6.749534118,8,0,0,,,1
O14531,DPYSL4,DPYL4_HUMAN,"cytosol [GO:0005829]; filamin binding [GO:0031005]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; nervous system development [GO:0007399]; neuron death [GO:0070997]; neuron projection guidance [GO:0097485]",SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.,Dihydropyrimidinase-related protein 4 (DRP-4) (Collapsin response mediator protein 3) (CRMP-3) (UNC33-like phosphoprotein 4) (ULIP-4),GO:0005829; GO:0007399; GO:0016810; GO:0031005; GO:0070997; GO:0097485,0.179777752,0.208990642,0.189959004,0.198382744,0.023618022,0.041385891,0.037090055,0.037902717,0.052490607,0.231430381,0.037902717,-0.187413619,0.132204268,-20.6934405,1.52E-08,3.20E-07,10.04911527,"61,878",6.494959075,30,0,0,,,1
Q5JTW2,CEP78,CEP78_HUMAN,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium organization [GO:0044782]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:14654843}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole {ECO:0000269|PubMed:27246242}. Cytoplasm, cytoskeleton, cilium basal body {ECO:0000269|PubMed:27588451}. Note=Mainly localizes at the centriolar wall, but also found in the pericentriolar material (PubMed:27246242). Expressed in photoreceptor inner segment (PubMed:27588452). {ECO:0000269|PubMed:27246242, ECO:0000269|PubMed:27588452}.",Centrosomal protein of 78 kDa (Cep78),GO:0000086; GO:0005813; GO:0005814; GO:0005829; GO:0010389; GO:0036064; GO:0044782; GO:0097711,0.530953827,0.525523229,0.517231849,0.541595309,0.233100619,0.137598975,0.247597886,0.224683193,0.202899013,0.607500392,0.224683193,-0.401132443,0.409742159,-19.79113714,2.20E-08,4.19E-07,9.643514774,"76,396",6.377454881,9,0,0,,1,1
Q9Y653,ADGRG1,AGRG1_HUMAN,extracellular exosome [GO:0070062]; glial limiting end-foot [GO:0097451]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular [GO:0005622]; membrane raft [GO:0045121]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G-protein coupled receptor activity [GO:0004930]; heparin binding [GO:0008201]; angiogenesis [GO:0001525]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cerebral cortex radial glia guided migration [GO:0021801]; cerebral cortex regionalization [GO:0021796]; G-protein coupled receptor signaling pathway [GO:0007186]; layer formation in cerebral cortex [GO:0021819]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron migration [GO:2001223]; positive regulation of cell adhesion [GO:0045785]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of Rho protein signal transduction [GO:0035025]; protein kinase C signaling [GO:0070528]; Rho protein signal transduction [GO:0007266]; seminiferous tubule development [GO:0072520]; vascular endothelial growth factor production [GO:0010573],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:21349848, ECO:0000269|PubMed:24949629}; Multi-pass membrane protein {ECO:0000255}.; SUBCELLULAR LOCATION: ADGRG1 N-terminal fragment: Secreted {ECO:0000269|PubMed:21349848}.; SUBCELLULAR LOCATION: ADGRG1 C-terminal fragment: Membrane raft {ECO:0000269|PubMed:24949629}. Note=Interaction with its ligand COL3A1 leads to the release of ADGRG1 NT from the membrane and triggers the association of ADGRG1 CT with lipid rafts. {ECO:0000269|PubMed:24949629}.",Adhesion G-protein coupled receptor G1 (G-protein coupled receptor 56) (Protein TM7XN1) [Cleaved into: ADGRG1 N-terminal fragment (ADGRG1 NT) (GPR56 N-terminal fragment) (GPR56 NT) (GPR56(N)) (GPR56 extracellular subunit) (GPR56 subunit alpha); ADGRG1 C-terminal fragment (ADGRG1 CT) (GPR56 C-terminal fragment) (GPR56 CT) (GPR56(C)) (GPR56 seven-transmembrane subunit) (GPR56 7TM) (GPR56 subunit beta)],GO:0001525; GO:0004930; GO:0005518; GO:0005622; GO:0005887; GO:0007155; GO:0007166; GO:0007186; GO:0007266; GO:0007267; GO:0007420; GO:0008201; GO:0008285; GO:0010573; GO:0016021; GO:0016477; GO:0021796; GO:0021801; GO:0021819; GO:0035025; GO:0045121; GO:0045785; GO:0050840; GO:0070062; GO:0070528; GO:0072520; GO:0097451; GO:2000179; GO:2001223,3.266806117,3.237777292,3.278054611,3.416310862,2.379018509,2.183864893,2.281641235,2.446790871,2.588626476,3.994419193,2.379018509,-1.683875466,3.21792613,-17.58017349,5.86E-08,8.54E-07,8.566707838,"77,738",6.068582068,9,0,0,,,1
Q9UPQ0,LIMCH1,LIMC1_HUMAN,actin binding [GO:0003779]; metal ion binding [GO:0046872]; actomyosin structure organization [GO:0031032],,LIM and calponin homology domains-containing protein 1,GO:0003779; GO:0031032; GO:0046872,0.359226649,0.349836188,0.3210226,0.368144674,0.168028062,0.122912804,0.180537249,0.207952141,0.198748536,0.583961916,0.180537249,-0.391871924,0.37157172,-15.54641923,1.61E-07,1.87E-06,7.452632065,"121,867",5.72725028,21,0,0,,,1
Q6P1L5,FAM117B,F117B_HUMAN,,,Protein FAM117B (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 13 protein),,0.553189701,0.624864054,0.685698998,0.647521411,0.18054251,0.08590537,0.187334707,0.10100373,0.218394473,0.846292194,0.18054251,-0.701647735,0.505460026,-14.60522899,2.69E-07,2.78E-06,6.888926744,"61,968",5.555944306,7,0,0,,,1
Q96AY4,TTC28,TTC28_HUMAN,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; spindle pole [GO:0000922]; kinase binding [GO:0019900]; cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000250}. Cytoplasm, cytoskeleton, spindle {ECO:0000250}. Cytoplasm, cytoskeleton, spindle pole {ECO:0000250}. Midbody {ECO:0000250}. Note=At interphase, localizes to centrosomes. At prometaphase and metaphase, associated with spindle microtubules and spindle poles. At anaphase, accumulates in the spindle midzone. At telophase, condensed on central spindles. During cytokinesis, condensed on the midbody where it colocalizes with AURKB (By similarity). {ECO:0000250}.",Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio),GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301,0.113166707,0.131786727,0.138261985,0.129791003,0.087596962,0.079322685,0.076747887,0.047230457,0.051852178,0.202578478,0.076747887,-0.136925789,0.137012928,-13.88871139,4.05E-07,3.80E-06,6.436305134,"270,884",5.41994995,55,0,0,,,1
O00214,LGALS8,LEG8_HUMAN,cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; carbohydrate binding [GO:0030246]; integrin binding [GO:0005178]; cellular response to virus [GO:0098586]; lymphatic endothelial cell migration [GO:1904977]; xenophagy [GO:0098792],"SUBCELLULAR LOCATION: Cytoplasmic vesicle {ECO:0000269|PubMed:22246324}. Cytoplasm, cytosol {ECO:0000269|PubMed:22246324}.",Galectin-8 (Gal-8) (Po66 carbohydrate-binding protein) (Po66-CBP) (Prostate carcinoma tumor antigen 1) (PCTA-1),GO:0005178; GO:0005615; GO:0005737; GO:0005829; GO:0016020; GO:0030246; GO:0031410; GO:0098586; GO:0098792; GO:1904977,0.858689094,0.416890514,0.30841725,0.486688274,1.00E-07,1.00E-07,1.00E-07,1.00E-07,1.00E-07,1.239068912,1.00E-07,-1.309033626,0.654516913,-13.83171014,4.19E-07,3.90E-06,6.399364503,"35,808",5.409358757,3,0,5,,,1
P49918,CDKN1C,CDN1C_HUMAN,"cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; protein kinase inhibitor activity [GO:0004860]; protein-containing complex binding [GO:0044877]; cell cycle arrest [GO:0007050]; negative regulation of cyclin-dependent protein kinase activity [GO:1904030]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of kinase activity [GO:0033673]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of mitotic cell cycle [GO:0007346]",SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.,Cyclin-dependent kinase inhibitor 1C (Cyclin-dependent kinase inhibitor p57) (p57Kip2),GO:0004860; GO:0004861; GO:0005634; GO:0005737; GO:0007050; GO:0007346; GO:0030511; GO:0033673; GO:0042326; GO:0044877; GO:0045892; GO:0045893; GO:0050680; GO:1904030,4.514870242,0.708001364,2.110409529,0.831381145,1.00E-07,1.00E-07,1.00E-07,1.00E-07,0.92334937,3.2163495,1.00E-07,-3.120435022,1.744887465,-13.72816174,4.45E-07,4.07E-06,6.331893535,"32,177",5.390165596,5,0,4,,,1
Q2VPB7,AP5B1,AP5B1_HUMAN,AP-type membrane coat adaptor complex [GO:0030119]; lysosomal membrane [GO:0005765]; endosomal transport [GO:0016197]; protein transport [GO:0015031],,AP-5 complex subunit beta-1 (Adaptor-related protein complex 5 beta subunit) (Beta5),GO:0005765; GO:0015031; GO:0016197; GO:0030119,0.062864402,0.136576863,0.126408017,0.155367589,1.00E-07,1.00E-07,1.00E-07,0.000135885,1.00E-07,0.219430482,1.00E-07,-0.241508782,0.120781648,-13.65712288,4.64E-07,4.21E-06,6.285330719,"93,949",5.375687576,9,0,4,,1,1
Q92974,ARHGEF2,ARHG2_HUMAN,bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; podosome [GO:0002102]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; spindle [GO:0005819]; vesicle [GO:0031982]; guanyl-nucleotide exchange factor activity [GO:0005085]; microtubule binding [GO:0008017]; Rac GTPase binding [GO:0048365]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; actin filament organization [GO:0007015]; asymmetric neuroblast division [GO:0055059]; cell morphogenesis [GO:0000902]; cellular hyperosmotic response [GO:0071474]; cellular response to muramyl dipeptide [GO:0071225]; cellular response to tumor necrosis factor [GO:0071356]; establishment of mitotic spindle orientation [GO:0000132]; G-protein coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; intracellular protein transport [GO:0006886]; intracellular signal transduction [GO:0035556]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of necroptotic process [GO:0060546]; negative regulation of neurogenesis [GO:0050768]; negative regulation of podosome assembly [GO:0071802]; positive regulation of apoptotic process [GO:0043065]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron migration [GO:2001224]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell proliferation [GO:0042127]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000269|PubMed:11912491, ECO:0000269|PubMed:21887730, ECO:0000269|PubMed:9857026}. Cytoplasm {ECO:0000269|PubMed:15827085, ECO:0000269|PubMed:21887730}. Cell junction, tight junction {ECO:0000269|PubMed:19043560}. Golgi apparatus {ECO:0000269|PubMed:15827085}. Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:17488622}. Cell projection, ruffle membrane {ECO:0000269|PubMed:19043560}. Cytoplasmic vesicle {ECO:0000269|PubMed:21887730}. Note=Localizes to the tips of cortical microtubules of the mitotic spindle during cell division, and is further released upon microtubule depolymerization (PubMed:15827085). Recruited into membrane ruffles induced by S.flexneri at tight junctions of polarized epithelial cells (PubMed:19043560). Colocalized with NOD2 and RIPK2 in vesicles and with the cytoskeleton (PubMed:21887730). {ECO:0000269|PubMed:15827085, ECO:0000269|PubMed:19043560, ECO:0000269|PubMed:21887730}.",Rho guanine nucleotide exchange factor 2 (Guanine nucleotide exchange factor H1) (GEF-H1) (Microtubule-regulated Rho-GEF) (Proliferating cell nucleolar antigen p40),GO:0000132; GO:0000902; GO:0002102; GO:0005085; GO:0005089; GO:0005737; GO:0005794; GO:0005819; GO:0005829; GO:0005856; GO:0005874; GO:0005923; GO:0005925; GO:0006886; GO:0007015; GO:0007026; GO:0007186; GO:0008017; GO:0008134; GO:0008270; GO:0014069; GO:0017048; GO:0030676; GO:0031410; GO:0031982; GO:0032587; GO:0032755; GO:0032760; GO:0032991; GO:0035023; GO:0035556; GO:0042127; GO:0043025; GO:0043065; GO:0043198; GO:0045087; GO:0045666; GO:0045944; GO:0048365; GO:0050731; GO:0050768; GO:0051056; GO:0051092; GO:0055059; GO:0060546; GO:0071225; GO:0071356; GO:0071474; GO:0071802; GO:1902042; GO:1902219; GO:2001224,0.258948965,0.232057016,0.284735223,0.297906541,0.200684443,0.215684224,0.203347897,0.16836286,0.164533094,0.338615072,0.200684443,-0.14562252,0.263333763,-13.27320543,5.86E-07,5.08E-06,6.029729427,"111,543",5.293944627,38,0,0,,,1
P43004,SLC1A2,EAA2_HUMAN,axolemma [GO:0030673]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; adult behavior [GO:0030534]; cellular response to extracellular stimulus [GO:0031668]; chemical synaptic transmission [GO:0007268]; D-aspartate import across plasma membrane [GO:0070779]; glutamate secretion [GO:0014047]; ion transport [GO:0006811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to wounding [GO:0009611]; telencephalon development [GO:0021537]; visual behavior [GO:0007632],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:14506254, ECO:0000269|PubMed:15265858, ECO:0000269|PubMed:26690923, ECO:0000269|PubMed:7521911}; Multi-pass membrane protein {ECO:0000305}.",Excitatory amino acid transporter 2 (Glutamate/aspartate transporter II) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2),GO:0005313; GO:0005314; GO:0005886; GO:0005887; GO:0006811; GO:0007268; GO:0007632; GO:0009611; GO:0009986; GO:0010259; GO:0014047; GO:0015171; GO:0015501; GO:0015813; GO:0016020; GO:0021537; GO:0030534; GO:0030673; GO:0031668; GO:0035264; GO:0043200; GO:0046326; GO:0046872; GO:0070207; GO:0070779; GO:0098712,0.531009839,0.719337982,0.487518778,0.747795003,0.266408134,0.411143095,0.271962061,0.276234516,0.311484466,0.83124726,0.276234516,-0.525922531,0.57040772,-12.2481223,1.12E-06,8.51E-06,5.31234262,"62,104",5.069916743,6,0,0,,,1
Q8N158,GPC2,GPC2_HUMAN,anchored component of plasma membrane [GO:0046658]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; heparan sulfate proteoglycan binding [GO:0043395]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; neuron differentiation [GO:0030182]; regulation of signal transduction [GO:0009966]; retinoid metabolic process [GO:0001523]; smoothened signaling pathway [GO:0007224],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Lipid-anchor, GPI-anchor {ECO:0000250}; Extracellular side {ECO:0000250}.; SUBCELLULAR LOCATION: Secreted glypican-2: Secreted, extracellular space {ECO:0000250}.",Glypican-2 [Cleaved into: Secreted glypican-2],GO:0001523; GO:0005615; GO:0005783; GO:0005796; GO:0005886; GO:0006024; GO:0006027; GO:0007224; GO:0009966; GO:0030182; GO:0043202; GO:0043395; GO:0046658,0.513643246,0.49682574,0.501579151,0.462298832,0.30118449,0.329448583,0.348875734,0.288592994,0.297036542,0.531976339,0.30118449,-0.210743408,0.418399372,-11.64662863,1.68E-06,1.19E-05,4.865553326,"62,830",4.924483113,20,0,0,,1,1
Q9BQ89,FAM110A,F110A_HUMAN,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17499476}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:17499476}. Cytoplasm, cytoskeleton, spindle pole {ECO:0000269|PubMed:17499476}. Note=Distributed throughout the cytoplasm during mitosis, accumulating at spindle poles.",Protein FAM110A,GO:0000922; GO:0005737; GO:0005815,2.133446801,2.395784575,2.004881561,2.333621564,1.376041438,1.691763447,1.525195518,1.844300909,1.343142093,3.417390355,1.525195518,-1.77143065,2.441804006,-10.73133766,3.23E-06,2.01E-05,4.144495197,"31,271",4.696969744,9,0,0,,1,1
Q9Y666,SLC12A7,S12A7_HUMAN,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; cell volume homeostasis [GO:0006884]; chemical synaptic transmission [GO:0007268]; ion transport [GO:0006811],SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.,Solute carrier family 12 member 7 (Electroneutral potassium-chloride cotransporter 4) (K-Cl cotransporter 4),GO:0005886; GO:0005887; GO:0006811; GO:0006884; GO:0007268; GO:0015379; GO:0019901,0.248664486,0.274144419,0.32116836,0.350461511,0.034419069,0.005661134,1.00E-07,0.006895556,0.001373173,0.398225732,0.005661134,-0.378719341,0.199029477,-10.45529544,3.97E-06,2.39E-05,3.916418445,"119,106",4.621051233,15,0,1,,1,1
Q7Z2K8,GPRIN1,GRIN1_HUMAN,growth cone [GO:0030426]; plasma membrane [GO:0005886]; neuron projection development [GO:0031175],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Lipid-anchor {ECO:0000250}. Cell projection, growth cone {ECO:0000250}. Note=Highly enriched in growth cone. {ECO:0000250}.",G protein-regulated inducer of neurite outgrowth 1 (GRIN1),GO:0005886; GO:0030426; GO:0031175,0.398756799,0.424033238,0.409157413,0.494453192,0.193123174,0.176911609,0.065473868,0.046159437,0.040455828,0.587923171,0.065473868,-0.504245213,0.35654739,-10.43798015,4.02E-06,2.42E-05,3.901938231,"102,399",4.616768298,12,0,0,,,1
Q6IQ32,ADNP2,ADNP2_HUMAN,"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; cellular response to oxidative stress [GO:0034599]; cellular response to retinoic acid [GO:0071300]; negative regulation of cell death [GO:0060548]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; transcription, DNA-templated [GO:0006351]",SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,Activity-dependent neuroprotector homeobox protein 2 (ADNP homeobox protein 2) (Zinc finger protein 508),GO:0000981; GO:0003677; GO:0005634; GO:0006351; GO:0030182; GO:0030307; GO:0034599; GO:0046872; GO:0060548; GO:0071300,0.301435999,0.288618614,0.248878909,0.285657006,0.001309194,0.037058325,0.018756886,0.066592674,0.017089803,0.243125019,0.018756886,-0.209754191,0.133038472,-10.24168847,4.67E-06,2.74E-05,3.736317667,"122,833",4.563032148,9,0,0,,,1
Q9Y5E7,PCDHB2,PCDB2_HUMAN,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; synapse assembly [GO:0007416],SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}.,Protocadherin beta-2 (PCDH-beta-2),GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007268; GO:0007399; GO:0007416; GO:0016021; GO:0016339,1.991276427,2.041024538,0.981595387,2.050341158,0.319287906,0.4257372,0.453742712,0.729007468,0.556834565,2.170452909,0.453742712,-1.720239122,1.357041532,-10.00717625,5.61E-06,3.21E-05,3.534831885,"87,254",4.493543501,3,0,0,,,1
Q9Y4F1,FARP1,FARP1_HUMAN,cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; filopodium [GO:0030175]; cytoskeletal protein binding [GO:0008092]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; dendrite morphogenesis [GO:0048813]; negative regulation of phosphatase activity [GO:0010923]; regulation of Rho protein signal transduction [GO:0035023]; synapse assembly [GO:0007416],"SUBCELLULAR LOCATION: Cell membrane; Peripheral membrane protein; Cytoplasmic side. Cell junction, synapse. Cell junction, synapse, synaptosome {ECO:0000250}. Cytoplasm, cytosol {ECO:0000250}. Cell projection, filopodium {ECO:0000250}. Cell projection, dendrite {ECO:0000250}. Cell projection, dendritic spine {ECO:0000250}. Note=Recruited to the cell membrane via interaction with CADM1. {ECO:0000250}.","FERM, ARHGEF and pleckstrin domain-containing protein 1 (Chondrocyte-derived ezrin-like protein) (FERM, RhoGEF and pleckstrin domain-containing protein 1) (Pleckstrin homology domain-containing family C member 2) (PH domain-containing family C member 2)",GO:0005089; GO:0005829; GO:0005856; GO:0007416; GO:0008092; GO:0010923; GO:0030054; GO:0030175; GO:0030425; GO:0030676; GO:0031234; GO:0035023; GO:0043197; GO:0048813,0.079349576,0.065666287,0.098409557,0.071482812,1.00E-07,0.001054883,1.00E-07,0.000114633,1.00E-07,0.060201294,1.00E-07,-0.067930394,0.03419916,-9.989987354,5.69E-06,3.25E-05,3.519905361,"118,633",4.488743995,33,0,3,,,1
Q68DQ2,CRYBG3,CRBG3_HUMAN,protein-containing complex [GO:0032991]; carbohydrate binding [GO:0030246]; protein kinase A binding [GO:0051018],,Very large A-kinase anchor protein (vlAKAP) (Beta/gamma crystallin domain-containing protein 3),GO:0030246; GO:0032991; GO:0051018,0.162834688,0.263807066,0.225903231,0.152709636,1.00E-07,1.00E-07,1.00E-07,0.02231066,1.00E-07,0.237866331,1.00E-07,-0.227674768,0.118299596,-9.74765472,6.90E-06,3.79E-05,3.307108913,"330,633",4.421317991,30,0,4,,,1
P55287,CDH11,CAD11_HUMAN,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; cell adhesion [GO:0007155]; corticospinal tract morphogenesis [GO:0021957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; ossification [GO:0001503]; skeletal system development [GO:0001501],SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane protein.,Cadherin-11 (OSF-4) (Osteoblast cadherin) (OB-cadherin),GO:0001501; GO:0001503; GO:0005509; GO:0005737; GO:0005886; GO:0007155; GO:0007156; GO:0016021; GO:0021957; GO:0034332; GO:0070062,1.477834522,1.401205779,1.291914427,1.262153977,1.076342893,1.032671554,1.244037521,1.072098485,0.906548659,1.564667707,1.072098485,-0.510867499,1.321773572,-8.631146204,1.77E-05,8.46E-05,2.265621158,"87,965",4.072732715,11,0,0,,,1
O95248,SBF1,MTMR5_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear body [GO:0016604]; phosphatase regulator activity [GO:0019208]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; phosphatidylinositol biosynthetic process [GO:0006661]; protein dephosphorylation [GO:0006470]; regulation of GTPase activity [GO:0043087]; spermatogenesis [GO:0007283],SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9537414}.,Myotubularin-related protein 5 (SET-binding factor 1) (Sbf1),GO:0005737; GO:0005789; GO:0005829; GO:0006470; GO:0006661; GO:0007283; GO:0008138; GO:0016021; GO:0016604; GO:0017112; GO:0019208; GO:0043087,0.057586272,0.080034282,0.123559446,0.095205268,0.011868209,1.00E-07,0.025537106,0.000289463,1.00E-07,0.195251468,0.000289463,-0.178999208,0.097038599,-8.597438276,1.83E-05,8.68E-05,2.232503414,"208,443",4.061471007,42,0,2,,1,1
P54284,CACNB3,CACB3_HUMAN,apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; L-type voltage-gated calcium channel complex [GO:1990454]; membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; calcium channel activity [GO:0005262]; high voltage-gated calcium channel activity [GO:0008331]; protein kinase binding [GO:0019901]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; cellular response to oxygen-glucose deprivation [GO:0090650]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; membrane depolarization [GO:0051899]; negative regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905788]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; neuromuscular junction development [GO:0007528]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of high voltage-gated calcium channel activity [GO:1901843]; positive regulation of protein targeting to membrane [GO:0090314]; protein localization to plasma membrane [GO:0072659]; regulation of membrane hyperpolarization [GO:1902630]; regulation of membrane repolarization during action potential [GO:0098903]; regulation of voltage-gated calcium channel activity [GO:1901385],,Voltage-dependent L-type calcium channel subunit beta-3 (CAB3) (Calcium channel voltage-dependent subunit beta 3),GO:0005245; GO:0005262; GO:0005829; GO:0005886; GO:0005891; GO:0006816; GO:0007268; GO:0007528; GO:0008331; GO:0016020; GO:0016324; GO:0019901; GO:0050966; GO:0051899; GO:0060402; GO:0061577; GO:0072659; GO:0090314; GO:0090650; GO:0098903; GO:1901385; GO:1901386; GO:1901843; GO:1902630; GO:1905788; GO:1990454; GO:2000463,0.158070904,0.177065534,0.164118303,0.255349699,1.00E-07,1.00E-07,1.00E-07,2.46E-05,1.00E-07,0.166972314,1.00E-07,-0.181004559,0.090507278,-8.50864726,1.98E-05,9.28E-05,2.144766832,"54,532",4.032657032,11,0,4,,,1
Q9HCM2,PLXNA4,PLXA4_HUMAN,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; anterior commissure morphogenesis [GO:0021960]; branchiomotor neuron axon guidance [GO:0021785]; chemorepulsion of branchiomotor axon [GO:0021793]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sympathetic nervous system development [GO:0048485]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644],SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.,Plexin-A4,GO:0002116; GO:0005886; GO:0016021; GO:0017154; GO:0021612; GO:0021615; GO:0021637; GO:0021644; GO:0021784; GO:0021785; GO:0021793; GO:0021960; GO:0048485; GO:0048841; GO:0050923; GO:0071526; GO:1902287,0.190197158,0.756543429,0.259839764,0.164771258,1.00E-07,1.00E-07,1.00E-07,9.26E-05,0.145714415,1.209253409,1.00E-07,-1.089840969,0.574081945,-8.274709426,2.45E-05,0.000111008,1.910070937,"212,455",3.954644214,13,0,3,,,1
Q8N1F7,NUP93,NUP93_HUMAN,membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; structural constituent of nuclear pore [GO:0017056]; glomerular visceral epithelial cell development [GO:0072015]; glomerular visceral epithelial cell migration [GO:0090521]; mRNA export from nucleus [GO:0006406]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; nuclear envelope organization [GO:0006998]; nuclear pore complex assembly [GO:0051292]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of SMAD protein signal transduction [GO:0060391]; renal system development [GO:0072001]; SMAD protein signal transduction [GO:0060395]; viral process [GO:0016032],"SUBCELLULAR LOCATION: Nucleus membrane {ECO:0000250|UniProtKB:Q66HC5}; Peripheral membrane protein {ECO:0000250|UniProtKB:Q66HC5}. Nucleus, nuclear pore complex {ECO:0000269|PubMed:12802065, ECO:0000269|PubMed:15229283, ECO:0000269|PubMed:9348540}. Nucleus envelope {ECO:0000269|PubMed:26878725, ECO:0000269|PubMed:9348540}. Note=Localizes at the nuclear basket and at or near the nuclear entry to the gated channel of the pore. {ECO:0000269|PubMed:9348540}.",Nuclear pore complex protein Nup93 (93 kDa nucleoporin) (Nucleoporin Nup93),GO:0005635; GO:0005643; GO:0006406; GO:0006998; GO:0016020; GO:0016032; GO:0016973; GO:0017056; GO:0031965; GO:0034399; GO:0051292; GO:0060391; GO:0060395; GO:0072001; GO:0072015; GO:0090521; GO:1903206,0.048644152,0.051067025,0.053267311,0.045945022,0.01229152,0.014892449,0.007990756,0.014991049,0.020488629,0.078224672,0.014892449,-0.058307604,0.043284682,-7.479306297,5.25E-05,0.000210873,1.07146471,"93,488",3.675979074,47,0,0,,1,1
O75351,VPS4B,VPS4B_HUMAN,"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; cell separation after cytokinesis [GO:0000920]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; late endosomal microautophagy [GO:0061738]; macroautophagy [GO:0016236]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cell death [GO:0060548]; negative regulation of exosomal secretion [GO:1903542]; nucleus organization [GO:0006997]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of viral life cycle [GO:1903902]; positive regulation of viral process [GO:0048524]; positive regulation of viral release from host cell [GO:1902188]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of viral process [GO:0050792]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]; viral release from host cell [GO:0019076]",SUBCELLULAR LOCATION: Prevacuolar compartment membrane; Peripheral membrane protein. Late endosome membrane {ECO:0000305}; Peripheral membrane protein {ECO:0000305}. Note=Membrane-associated in the prevacuolar endosomal compartment. Localized in HIV-1 particles purified from acutely infected cells.,Vacuolar protein sorting-associated protein 4B (EC 3.6.4.6) (Cell migration-inducing gene 1 protein) (Suppressor of K(+) transport growth defect 1) (Protein SKD1),GO:0000920; GO:0000922; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005813; GO:0005829; GO:0006813; GO:0006997; GO:0007080; GO:0008022; GO:0010008; GO:0010824; GO:0010971; GO:0015031; GO:0016197; GO:0016236; GO:0016887; GO:0019058; GO:0019076; GO:0030301; GO:0031902; GO:0032510; GO:0033993; GO:0036258; GO:0039702; GO:0042623; GO:0042802; GO:0042803; GO:0043162; GO:0048524; GO:0050792; GO:0051261; GO:0060548; GO:0061738; GO:0070062; GO:0090543; GO:0090611; GO:1901673; GO:1902188; GO:1903542; GO:1903543; GO:1903724; GO:1903902; GO:1904903,0.121843739,0.156273697,0.170533802,0.103415641,0.104357961,0.11328605,0.145818375,0.083890553,0.103363145,0.236069329,0.104357961,-0.126705464,0.173495949,-7.468604687,5.30E-05,0.000212397,1.059730651,"49,302",3.672851105,13,0,0,,1,1
Q9P107,GMIP,GMIP_HUMAN,cytosol [GO:0005829]; intracellular [GO:0005622]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; negative regulation of GTPase activity [GO:0034260]; regulation of small GTPase mediated signal transduction [GO:0051056],,GEM-interacting protein (GMIP),GO:0005096; GO:0005622; GO:0005654; GO:0005829; GO:0005886; GO:0034260; GO:0035556; GO:0046872; GO:0051056,0.283786669,0.28243327,0.294240132,0.289418163,0.118782219,0.151686579,0.17127293,0.192473363,0.150881272,0.298898672,0.151686579,-0.161900782,0.237969664,-6.786270586,0.000107373,0.000394427,0.284945739,"106,683",3.404033133,21,0,0,,1,1
O75781,PALM,PALM_HUMAN,apicolateral plasma membrane [GO:0016327]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; dendritic spine membrane [GO:0032591]; filopodium membrane [GO:0031527]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; D3 dopamine receptor binding [GO:0031750]; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway [GO:0007193]; cellular response to electrical stimulus [GO:0071257]; cytoskeleton organization [GO:0007010]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of dopamine receptor signaling pathway [GO:0060160]; positive regulation of filopodium assembly [GO:0051491]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]; synapse maturation [GO:0060074],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:14978216}; Lipid-anchor {ECO:0000269|PubMed:14978216}; Cytoplasmic side {ECO:0000269|PubMed:14978216}. Cell projection, filopodium membrane {ECO:0000269|PubMed:14978216}; Lipid-anchor {ECO:0000269|PubMed:14978216}. Cell projection, axon {ECO:0000250}. Cell projection, dendrite {ECO:0000250}. Cell projection, dendritic spine {ECO:0000250}. Basolateral cell membrane {ECO:0000250}; Lipid-anchor {ECO:0000250}. Apicolateral cell membrane {ECO:0000250}; Lipid-anchor {ECO:0000250}. Note=Translocation to the plasma membrane is enhanced upon stimulation of neuronal activity.",Paralemmin-1 (Paralemmin),GO:0005634; GO:0005886; GO:0005887; GO:0007010; GO:0007193; GO:0007194; GO:0008360; GO:0014069; GO:0016323; GO:0016327; GO:0030424; GO:0031410; GO:0031527; GO:0031750; GO:0032591; GO:0043231; GO:0051491; GO:0060074; GO:0060160; GO:0071257; GO:0072659,0.090769532,1.00E-07,0.002066114,1.00E-07,1.00E-07,1.00E-07,0.049181178,1.00E-07,1.00E-07,0.148616168,1.00E-07,-0.141298411,0.080485521,-6.739942048,0.000112853,0.000410802,0.230371225,"42,076",3.386367141,9,0,4,,1,1
Q75N90,FBN3,FBN3_HUMAN,extracellular matrix [GO:0031012]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; anatomical structure morphogenesis [GO:0009653]; regulation of cellular response to growth factor stimulus [GO:0090287],"SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix {ECO:0000269|PubMed:14962672}.",Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide],GO:0005201; GO:0005509; GO:0009653; GO:0031012; GO:0090287,0.111619605,0.067845613,0.047405402,1.00E-07,1.00E-07,1.00E-07,1.00E-07,1.00E-07,1.00E-07,0.272176663,1.00E-07,-0.261571032,0.130785616,-6.602763663,0.000130963,0.000467485,0.067248799,"300,356",3.330232665,3,0,5,,,1
Q9Y216,MTMR7,MTMR7_HUMAN,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine phosphatase activity [GO:0004725]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]",SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16787938}.,Myotubularin-related protein 7 (EC 3.1.3.-),GO:0004438; GO:0004725; GO:0005737; GO:0005829; GO:0006470; GO:0006661; GO:0016020; GO:0046855; GO:0046856; GO:0052629,0.168230991,1.00E-07,1.00E-07,1.00E-07,0.254814675,1.00E-07,1.00E-07,1.00E-07,1.00E-07,14.64119753,1.00E-07,-12.2533143,6.177620167,-6.560925051,0.000137105,0.000487193,0.017038275,"75,833",3.312299233,14,0,4,,1,1
Q9Y3S1,WNK2,WNK2_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; negative regulation of cell proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17667937, ECO:0000269|PubMed:18593598}. Cell membrane {ECO:0000269|PubMed:18593598}.",Serine/threonine-protein kinase WNK2 (EC 2.7.11.1) (Antigen NY-CO-43) (Protein kinase lysine-deficient 2) (Protein kinase with no lysine 2) (Serologically defined colon cancer antigen 43),GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0008285; GO:0035556; GO:0046777; GO:0050801; GO:0070373; GO:0090263; GO:2000651,0.087613467,0.180184996,0.102981861,0.212237595,1.00E-07,1.00E-07,1.00E-07,0.00017119,1.00E-07,0.282575617,1.00E-07,-0.266542079,0.133305358,-6.495089817,0.00014742,0.000519453,-0.062409804,"242,676",3.284453525,25,0,4,,,1
Q8IV36,HID1,HID1_HUMAN,cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; intracellular protein transport [GO:0006886]; response to brefeldin A [GO:0031001],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:21337012}. Golgi apparatus membrane {ECO:0000269|PubMed:21337012}; Lipid-anchor {ECO:0000269|PubMed:21337012}. Note=Shuttles between the cytosol and the Golgi apparatus.,Protein HID1 (Down-regulated in multiple cancers 1) (HID1 domain-containing protein) (Protein hid-1 homolog),GO:0000138; GO:0005737; GO:0005794; GO:0005797; GO:0005829; GO:0005881; GO:0006886; GO:0031001; GO:0070062; GO:0090498,0.139079971,0.126394562,0.131983501,0.150181158,1.00E-07,1.00E-07,1.00E-07,1.00E-07,1.00E-07,0.501417449,1.00E-07,-0.471698462,0.235849331,-6.265415435,0.000190647,0.000648299,-0.343839893,"88,745",3.188224779,11,0,5,,,1
Q96EK9,KTI12,KTI12_HUMAN,ATP binding [GO:0005524],,Protein KTI12 homolog,GO:0005524,0.104525763,0.153861926,0.055479135,0.09006165,0.041763391,0.047409449,0.127127007,0.031224284,0.025681394,0.189045596,0.041763391,-0.127751124,0.118516667,-5.90012883,0.000290882,0.000937614,-0.805465261,"38,616",3.027975958,13,0,0,,1,1
Q4AC94,C2CD3,C2CD3_HUMAN,centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; brain development [GO:0007420]; centriole elongation [GO:0061511]; ciliary basal body-plasma membrane docking [GO:0097711]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; neural plate axis specification [GO:0021997]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539]; protein processing [GO:0016485]; regulation of proteolysis [GO:0030162]; regulation of smoothened signaling pathway [GO:0008589],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, cilium basal body {ECO:0000250}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole {ECO:0000269|PubMed:23769972, ECO:0000269|PubMed:24997988}. Note=Localizes to centrioles and procentrioles both in interphase and mitosis. Localizes to centriolar satellites, localization is dependent on PCM1 and dynein-mediated retrograde transport. Also localizes to the distal ends of the mother and daughter centrioles.",C2 domain-containing protein 3,GO:0001701; GO:0001947; GO:0005813; GO:0005814; GO:0005829; GO:0007420; GO:0008589; GO:0016485; GO:0021915; GO:0021997; GO:0030162; GO:0034451; GO:0036064; GO:0042733; GO:0061511; GO:0071539; GO:0097711; GO:1905515,0.311856918,0.396885345,0.357997181,0.136110683,1.00E-07,1.00E-07,1.00E-07,1.00E-07,1.00E-07,0.612213745,1.00E-07,-0.620219809,0.310110005,-5.159926577,0.000722843,0.002067885,-1.796068148,"260,389",2.684473615,3,0,5,,,1
Q5H9R4,ARMCX4,ARMX4_HUMAN,integral component of membrane [GO:0016021],SUBCELLULAR LOCATION: Membrane {ECO:0000255}; Single-pass membrane protein {ECO:0000255}.,Armadillo repeat-containing X-linked protein 4,GO:0016021,0.032135427,0.052474942,0.052512833,0.068567873,1.00E-07,1.00E-07,0.023444667,0.000100081,1.00E-07,0.139719661,1.00E-07,-0.125344364,0.067381192,-5.147578221,0.000734376,0.002097633,-1.813237532,"39,406",2.67827059,13,0,3,,,1
P22830,FECH,HEMH_HUMAN,"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; ferrochelatase activity [GO:0004325]; ferrous iron binding [GO:0008198]; cellular response to dexamethasone stimulus [GO:0071549]; generation of precursor metabolites and energy [GO:0006091]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX metabolic process [GO:0046501]; response to arsenic-containing substance [GO:0046685]; response to ethanol [GO:0045471]; response to insecticide [GO:0017085]; response to lead ion [GO:0010288]; response to light stimulus [GO:0009416]; response to methylmercury [GO:0051597]; response to platinum ion [GO:0070541]",SUBCELLULAR LOCATION: Mitochondrion inner membrane; Peripheral membrane protein; Matrix side.,"Ferrochelatase, mitochondrial (EC 4.99.1.1) (Heme synthase) (Protoheme ferro-lyase)",GO:0004325; GO:0005739; GO:0005743; GO:0005759; GO:0006091; GO:0006783; GO:0008198; GO:0009416; GO:0010288; GO:0017085; GO:0045471; GO:0046501; GO:0046685; GO:0051537; GO:0051597; GO:0070541; GO:0071549,1.00E-07,1.00E-07,1.00E-07,1.00E-07,0.098533471,0.10340501,0.038258186,0.128519095,0.053634326,1.00E-07,0.098533471,0.082532757,0.043203639,5.062563777,0.000819411,0.002307027,-1.932023071,"47,862",2.636947229,12,3,0,,,1
O14559,ARHGAP33,RHG33_HUMAN,actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901]; protein transport [GO:0015031]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to toxic substance [GO:0009636]; small GTPase mediated signal transduction [GO:0007264],,Rho GTPase-activating protein 33 (Rho-type GTPase-activating protein 33) (Sorting nexin-26) (Tc10/CDC42 GTPase-activating protein),GO:0005096; GO:0005829; GO:0005886; GO:0005938; GO:0007264; GO:0009636; GO:0015031; GO:0015629; GO:0019901; GO:0032991; GO:0035091; GO:0043197; GO:0051056; GO:0061001,0.16536451,0.18160633,0.253304843,0.139430982,1.00E-07,0.08217884,1.00E-07,1.00E-07,1.00E-07,0.279830889,1.00E-07,-0.223946196,0.128408946,-5.026931618,0.000858182,0.002403013,-1.982111029,"137,213",2.619243881,9,0,4,,,1
Q5U5Q3,MEX3C,MEX3C_HUMAN,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transferase activity [GO:0016740]; chondrocyte hypertrophy [GO:0003415]; energy homeostasis [GO:0097009]; regulation of fat cell differentiation [GO:0045598],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17267406}. Nucleus {ECO:0000269|PubMed:17267406}. Note=Predominantly expressed in the cytoplasm and shuttles between the cytoplasm and the nucleus through the CRM1 export pathway. May act as suppressor of replication stress and chromosome missegregation.,RNA-binding E3 ubiquitin-protein ligase MEX3C (EC 2.3.2.27) (RING finger and KH domain-containing protein 2) (RING finger protein 194) (RING-type E3 ubiquitin transferase MEX3C),GO:0003415; GO:0003723; GO:0005634; GO:0005737; GO:0016740; GO:0045598; GO:0046872; GO:0097009,1.821548288,3.907397644,4.521159612,3.480481287,1.855366608,1.236290681,0.599214581,0.625582185,1.968319604,2.695890775,1.236290681,-1.404558642,1.959234053,-4.877923887,0.001043275,0.002854727,-2.193498437,"69,366",2.544435353,4,0,0,,,1
Q7Z6J6,FRMD5,FRMD5_HUMAN,adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; cytoskeletal protein binding [GO:0008092]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; structural constituent of cytoskeleton [GO:0005200]; actomyosin structure organization [GO:0031032]; negative regulation of cell motility [GO:2000146]; positive regulation of cell adhesion [GO:0045785]; regulation of cell migration [GO:0030334],"SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass membrane protein {ECO:0000305}. Cell junction, adherens junction {ECO:0000269|PubMed:22846708}.",FERM domain-containing protein 5,GO:0005178; GO:0005200; GO:0005856; GO:0005912; GO:0008092; GO:0016021; GO:0019901; GO:0030334; GO:0031032; GO:0045785; GO:2000146,0.299077228,0.285228849,0.442937876,0.455134536,1.00E-07,0.260861074,1.00E-07,0.00024215,0.149944276,0.430708818,0.00024215,-0.331633852,0.248026466,-4.800978877,0.001155433,0.003125552,-2.303871577,"65,065",2.505073288,4,0,2,,1,1
Q96JJ7,TMX3,TMX3_HUMAN,cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; protein disulfide isomerase activity [GO:0003756]; thiol oxidase activity [GO:0016972]; cell redox homeostasis [GO:0045454]; peptidyl-cysteine oxidation [GO:0018171]; platelet degranulation [GO:0002576]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976],SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:15623505}; Single-pass membrane protein {ECO:0000269|PubMed:15623505}.,Protein disulfide-isomerase TMX3 (EC 5.3.4.1) (Thioredoxin domain-containing protein 10) (Thioredoxin-related transmembrane protein 3),GO:0002576; GO:0003756; GO:0005789; GO:0005886; GO:0006457; GO:0009986; GO:0016021; GO:0016972; GO:0018171; GO:0031092; GO:0034976; GO:0045454,0.031163794,0.067549121,0.104297902,0.066365671,0.003246741,1.00E-07,0.000762506,0.012307719,0.024866133,0.041465482,0.003246741,-0.031900658,0.024186969,-4.717205483,0.001292564,0.003448079,-2.424978035,"51,872",2.462422741,14,0,1,,,1
Q9UKF7,PITPNC1,PITC1_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; phosphatidic acid binding [GO:0070300]; phosphatidylglycerol binding [GO:1901611]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transporter activity [GO:0008526]; phospholipid transport [GO:0015914]; signal transduction [GO:0007165],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10531358}.,Cytoplasmic phosphatidylinositol transfer protein 1 (Mammalian rdgB homolog beta) (M-rdgB beta) (MrdgBbeta) (Retinal degeneration B homolog beta) (RdgBbeta),GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0008526; GO:0015914; GO:0035091; GO:0070300; GO:1901611,0.006314347,1.00E-07,1.00E-07,1.00E-07,0.373763593,0.173476754,0.165075313,0.242272874,0.494386496,1.00E-07,0.242272874,0.289794906,0.144897553,4.705554958,0.001312989,0.003496513,-2.44189778,"38,388",2.456364876,9,5,0,,,1
Q05682,CALD1,CALD1_HUMAN,actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; myofibril [GO:0030016]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; myosin binding [GO:0017022]; tropomyosin binding [GO:0005523]; muscle contraction [GO:0006936],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250}. Cytoplasm, myofibril {ECO:0000250}. Note=On thin filaments in smooth muscle and on stress fibers in fibroblasts (nonmuscle). {ECO:0000250}.",Caldesmon (CDM),GO:0003779; GO:0005516; GO:0005523; GO:0005829; GO:0005856; GO:0005886; GO:0006936; GO:0015629; GO:0017022; GO:0030016; GO:0030478; GO:0043231; GO:0045296,1.00E-07,1.00E-07,0.010943419,0.009412234,0.010494358,0.011898063,0.003372643,0.013459208,0.018006398,1.00E-07,0.011898063,0.011404979,0.005743644,4.686671151,0.001346839,0.003573278,-2.469362184,"93,231",2.446933201,33,4,0,,,1
Q92625,ANKS1A,ANS1A_HUMAN,cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; ephrin receptor binding [GO:0046875]; ephrin receptor signaling pathway [GO:0048013]; neuron remodeling [GO:0016322]; regulation of ephrin receptor signaling pathway [GO:1901187]; substrate-dependent cell migration [GO:0006929],SUBCELLULAR LOCATION: Cytoplasm. Cell projection {ECO:0000250}. Note=Cytoplasmic before and after growth factor treatment.,Ankyrin repeat and SAM domain-containing protein 1A (Odin),GO:0005654; GO:0005829; GO:0006929; GO:0016322; GO:0043005; GO:0046875; GO:0048013; GO:1901187,0.059877869,0.064822951,0.060150774,1.00E-07,0.177339749,0.213561762,0.144119153,0.155718052,0.080164489,0.040422437,0.155718052,0.110664557,0.098848363,4.613613631,0.001486954,0.003910233,-2.576080458,"123,108",2.407797328,27,0,0,,,1
Q3KQV9,UAP1L1,UAP1L_HUMAN,cytosol [GO:0005829]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048],,UDP-N-acetylhexosamine pyrophosphorylase-like protein 1 (EC 2.7.7.-),GO:0003977; GO:0005829; GO:0006048,0.125811538,0.168034326,0.113160851,0.13165625,0.239092286,0.257847489,0.240363494,0.130166156,0.142375485,0.335121623,0.239092286,-0.130600428,0.267269196,-4.51899468,0.00169227,0.004390217,-2.715384494,"57,030",2.357514039,7,0,0,,1,1
C9JLR9,C11orf95,CK095_HUMAN,nucleic acid binding [GO:0003676],,Uncharacterized protein C11orf95,GO:0003676,1.356207104,1.291436308,1.259720211,1.285207891,1.00E-07,1.00E-07,1.00E-07,1.00E-07,1.00E-07,1.02917353,1.00E-07,-0.920334942,0.460167571,-4.451194608,0.001858109,0.004773569,-2.815953937,"73,197",2.321156766,5,0,5,,,1
Q9HCM3,KIAA1549,K1549_HUMAN,"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]",SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.,UPF0606 protein KIAA1549,GO:0000981; GO:0005886; GO:0016021,0.094106625,0.036452614,0.106682004,0.046977808,1.00E-07,1.00E-07,0.046275394,0.035727225,0.000109834,0.205842095,0.000109834,-0.215447995,0.124146528,-4.440219616,0.001886562,0.004837257,-2.832291818,"210,755",2.315400832,14,0,2,,1,1
Q96A83,COL26A1,COQA1_HUMAN,collagen trimer [GO:0005581]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; positive regulation of cell-substrate adhesion [GO:0010811],"SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix.",Collagen alpha-1(XXVI) chain (Alpha-1 type XXVI collagen) (EMI domain-containing protein 2) (Emilin and multimerin domain-containing protein 2) (Emu2),GO:0005576; GO:0005581; GO:0005788; GO:0005794; GO:0005886; GO:0010811; GO:0031012,0.280070119,0.292171564,0.299948338,0.269774357,0.288143789,0.010958549,1.00E-07,0.013112803,0.062459412,0.377812735,0.013112803,-0.304447032,0.227158447,-4.310228429,0.002261644,0.005681783,-3.027026904,"45,381",2.245515348,6,0,1,,1,1
P52757,CHN2,CHIO_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; SH3/SH2 adaptor activity [GO:0005070]; intracellular signal transduction [GO:0035556]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Peripheral membrane protein {ECO:0000305}.,Beta-chimaerin (Beta-chimerin) (Rho GTPase-activating protein 3),GO:0005070; GO:0005096; GO:0005737; GO:0005829; GO:0016020; GO:0035556; GO:0043087; GO:0046872; GO:0051056,0.427927436,0.370344157,0.36558183,0.15292912,1.00E-07,1.00E-07,0.477720883,0.000113816,0.183216548,0.709538936,0.000113816,-0.512742564,0.388581571,-4.154292111,0.002820394,0.00692994,-3.263549421,"53,924",2.159270512,10,0,2,,1,1
O00221,NFKBIE,IKBE_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cytoplasmic sequestering of transcription factor [GO:0042994]; D-serine transport [GO:0042942],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.,NF-kappa-B inhibitor epsilon (NF-kappa-BIE) (I-kappa-B-epsilon) (IkB-E) (IkB-epsilon) (IkappaBepsilon),GO:0001650; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0042942; GO:0042994; GO:0048471,0.452078106,0.471466436,0.579527251,0.371163656,1.00E-07,1.00E-07,1.00E-07,1.00E-07,1.00E-07,0.179355405,1.00E-07,-0.232935222,0.116467711,-3.946565721,0.003805479,0.009080118,-3.583362042,"52,864",2.041908499,4,0,5,,,1
Q9NS39,ADARB2,RED2_HUMAN,nucleus [GO:0005634]; adenosine deaminase activity [GO:0004000]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; mRNA processing [GO:0006397],SUBCELLULAR LOCATION: Nucleus.,Double-stranded RNA-specific editase B2 (EC 3.5.-.-) (RNA-dependent adenosine deaminase 3) (RNA-editing deaminase 2) (RNA-editing enzyme 2) (dsRNA adenosine deaminase B2),GO:0003723; GO:0003725; GO:0003727; GO:0004000; GO:0005634; GO:0006397; GO:0046872,1.070900532,1.051156535,1.161041685,1.001067557,2.375166287,1.40332966,2.300805849,1.936352245,2.833031969,1.229571565,2.300805849,0.930320869,1.704576768,3.850535068,0.004379777,0.010319932,-3.732939836,"80,621",1.986323145,9,0,0,,1,1
P83876,TXNL4A,TXN4A_HUMAN,"cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20858735}.,Thioredoxin-like protein 4A (DIM1 protein homolog) (Spliceosomal U5 snRNP-specific 15 kDa protein) (Thioredoxin-like U5 snRNP protein U5-15kD),GO:0000245; GO:0000375; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005829; GO:0007049; GO:0031965; GO:0046540; GO:0051301,0.298769637,0.210324683,0.353892392,0.225084944,0.198205333,0.128285243,0.141309191,0.17118398,0.114476947,0.286641801,0.141309191,-0.151869762,0.22662702,-3.778357776,0.004871899,0.011346589,-3.846042549,"16,786",1.945134682,6,0,0,,,1
Q9Y5B0,CTDP1,CTDP1_HUMAN,"centrosome [GO:0005813]; cytoplasm [GO:0005737]; DNA-directed RNA polymerase II, holoenzyme [GO:0016591]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; CTD phosphatase activity [GO:0008420]; phosphoprotein phosphatase activity [GO:0004721]; Tat protein binding [GO:0030957]; TFIIF-class transcription factor binding [GO:0001096]; cell division [GO:0051301]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; exit from mitosis [GO:0010458]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation by host of viral transcription [GO:0043923]; protein dephosphorylation [GO:0006470]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:22692537}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:22692537}. Cytoplasm, cytoskeleton, spindle pole {ECO:0000269|PubMed:22692537}. Midbody {ECO:0000269|PubMed:22692537}. Note=Found at centrosomes in prometaphase, at spindle and spindle poles in metaphase and at spindle midzone and midbody in anaphase and telophase-G1 respectively.",RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase),GO:0000922; GO:0001096; GO:0004721; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0006366; GO:0006368; GO:0006470; GO:0008420; GO:0010458; GO:0016591; GO:0030496; GO:0030957; GO:0032991; GO:0043231; GO:0043923; GO:0051233; GO:0051301; GO:0061052; GO:0070940,0.016776799,0.041436966,0.020461251,0.010645231,1.00E-07,1.00E-07,1.00E-07,6.48E-05,1.00E-07,0.020378001,1.00E-07,-0.026408066,0.013217079,-3.641852963,0.005970374,0.013603273,-4.061446052,"104,399",1.866356586,19,0,4,,1,1
Q86YR5,GPSM1,GPSM1_HUMAN,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; GDP-dissociation inhibitor activity [GO:0005092]; cell differentiation [GO:0030154]; negative regulation of GTPase activity [GO:0034260]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; nervous system development [GO:0007399]; positive regulation of macroautophagy [GO:0016239],"SUBCELLULAR LOCATION: Cytoplasm, cytosol. Endoplasmic reticulum membrane; Peripheral membrane protein; Cytoplasmic side. Golgi apparatus membrane; Peripheral membrane protein; Cytoplasmic side. Cell membrane; Peripheral membrane protein; Cytoplasmic side.",G-protein-signaling modulator 1 (Activator of G-protein signaling 3),GO:0000139; GO:0005092; GO:0005789; GO:0005829; GO:0005886; GO:0007399; GO:0016239; GO:0030154; GO:0032991; GO:0034260; GO:1905098,0.040436949,0.038821818,1.00E-07,0.056086958,0.067128095,0.021516344,0.02490273,0.104166096,0.067379876,0.219203241,0.067128095,-0.130477247,0.122257252,-3.616184544,0.00620478,0.014092212,-4.102157717,"74,510",1.851020827,22,0,0,,1,1
P08138,NGFR,TNR16_HUMAN,cell surface [GO:0009986]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; coreceptor activity [GO:0015026]; death receptor activity [GO:0005035]; nerve growth factor binding [GO:0048406]; neurotrophin binding [GO:0043121]; Rab GTPase binding [GO:0017137]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; tumor necrosis factor-activated receptor activity [GO:0005031]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; axon guidance [GO:0007411]; cellular response to amyloid-beta [GO:1904646]; circadian regulation of gene expression [GO:0032922]; glucose homeostasis [GO:0042593]; immune response [GO:0006955]; inflammatory response [GO:0006954]; intracellular protein transport [GO:0006886]; membrane protein intracellular domain proteolysis [GO:0031293]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axonogenesis [GO:0050771]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron projection development [GO:0010977]; neuron apoptotic process [GO:0051402]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of apoptotic process [GO:0043065]; positive regulation of axonogenesis [GO:0050772]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein localization to nucleus [GO:1900182]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of glucose import in response to insulin stimulus [GO:2001273]; response to lipopolysaccharide [GO:0032496]; Rho protein signal transduction [GO:0007266],SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.,Tumor necrosis factor receptor superfamily member 16 (Gp80-LNGFR) (Low affinity neurotrophin receptor p75NTR) (Low-affinity nerve growth factor receptor) (NGF receptor) (p75 ICD) (CD antigen CD271),GO:0004888; GO:0005031; GO:0005035; GO:0005516; GO:0005576; GO:0005634; GO:0005654; GO:0005768; GO:0005829; GO:0005886; GO:0005887; GO:0006886; GO:0006919; GO:0006954; GO:0006955; GO:0007266; GO:0007411; GO:0009986; GO:0010977; GO:0015026; GO:0016021; GO:0017137; GO:0031293; GO:0031625; GO:0032496; GO:0032922; GO:0038023; GO:0042593; GO:0043005; GO:0043065; GO:0043066; GO:0043121; GO:0043154; GO:0043281; GO:0048011; GO:0048406; GO:0050771; GO:0050772; GO:0051402; GO:0097190; GO:1900182; GO:1902895; GO:1903588; GO:1904646; GO:2001273,0.396558137,0.323341924,0.189099816,0.233322424,1.216570637,1.532597095,1.787201885,0.726262697,1.447022856,0.178658397,1.447022856,0.950928612,0.866466728,3.610456934,0.006258402,0.014196561,-4.111250601,"45,183",1.847816843,3,0,0,,1,1
Q92796,DLG3,DLG3_HUMAN,AMPA glutamate receptor complex [GO:0032281]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular space [GO:0005615]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; guanylate kinase activity [GO:0004385]; ionotropic glutamate receptor binding [GO:0035255]; kinase binding [GO:0019900]; ligand-gated ion channel activity [GO:0015276]; PDZ domain binding [GO:0030165]; phosphatase binding [GO:0019902]; protein C-terminus binding [GO:0008022]; protein phosphatase binding [GO:0019903]; ubiquitin protein ligase binding [GO:0031625]; chemical synaptic transmission [GO:0007268]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; negative regulation of cell proliferation [GO:0008285]; negative regulation of phosphatase activity [GO:0010923]; nervous system development [GO:0007399]; positive regulation of protein tyrosine kinase activity [GO:0061098]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120],,Disks large homolog 3 (Neuroendocrine-DLG) (Synapse-associated protein 102) (SAP-102) (SAP102) (XLMR),GO:0001736; GO:0004385; GO:0005615; GO:0005829; GO:0005886; GO:0005923; GO:0007268; GO:0007399; GO:0008022; GO:0008285; GO:0010923; GO:0014069; GO:0015276; GO:0016323; GO:0019900; GO:0019902; GO:0019903; GO:0030165; GO:0030426; GO:0031625; GO:0032281; GO:0035255; GO:0043025; GO:0043113; GO:0043198; GO:0045197; GO:0045211; GO:0061098; GO:0097120,0.150046295,0.148859715,0.127436452,0.08053983,1.00E-07,0.03142905,1.00E-07,0.003296342,1.00E-07,0.067888066,1.00E-07,-0.055877378,0.034883828,-3.524826221,0.007121206,0.015919408,-4.247552521,"90,314",1.798073096,12,0,3,,,1
Q86UU1,PHLDB1,PHLB1_HUMAN,basal cortex [GO:0045180]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507],,Pleckstrin homology-like domain family B member 1 (Protein LL5-alpha),GO:0010470; GO:0010717; GO:0045180; GO:0070507; GO:1904261,0.061672575,1.00E-07,0.005243509,0.012102308,0.042040162,0.009509817,0.115449999,0.048929059,0.019234542,0.160795639,0.042040162,-0.093131686,0.093598559,-3.377821481,0.008907868,0.019475561,-4.482985921,"151,162",1.710510025,24,0,0,,,1
Q8IVF7,FMNL3,FMNL3_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; GTPase activating protein binding [GO:0032794]; Rho GTPase binding [GO:0017048]; actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:21834987}. Cell membrane {ECO:0000269|PubMed:22275430}; Lipid-anchor {ECO:0000255}. Note=Enriched in lamellipodia.,Formin-like protein 3 (Formin homology 2 domain-containing protein 3) (WW domain-binding protein 3) (WBP-3),GO:0001525; GO:0003779; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007010; GO:0008360; GO:0016477; GO:0017048; GO:0030036; GO:0032794; GO:0043231,0.072861959,0.095253392,0.094095219,0.122723214,1.00E-07,1.00E-07,1.00E-07,0.084452676,0.000513007,0.130968655,1.00E-07,-0.101756939,0.067871666,-3.291852866,0.010165903,0.021904903,-4.621400128,"117,213",1.659458663,11,0,3,,,1
Q06136,KDSR,KDSR_HUMAN,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 3-dehydrosphinganine reductase activity [GO:0047560]; 3-keto-sphinganine metabolic process [GO:0006666]; sphingolipid biosynthetic process [GO:0030148],SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:15328338}; Multi-pass membrane protein {ECO:0000269|PubMed:15328338}.,3-ketodihydrosphingosine reductase (KDS reductase) (EC 1.1.1.102) (3-dehydrosphinganine reductase) (Follicular variant translocation protein 1) (FVT-1) (Short chain dehydrogenase/reductase family 35C member 1),GO:0005615; GO:0005783; GO:0005789; GO:0006666; GO:0016020; GO:0016021; GO:0030148; GO:0047560,0.201229062,0.191160938,0.11436579,0.083567282,0.08764049,0.056798929,0.076734855,0.06720482,0.030421017,0.168347078,0.06720482,-0.093346524,0.110433285,-3.289516901,0.01020258,0.02197881,-4.625167774,"36,187",1.657995821,6,0,0,,,1
P54762,EPHB1,EPHB1_HUMAN,axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium tip [GO:0032433]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; transmembrane-ephrin receptor activity [GO:0005005]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; camera-type eye morphogenesis [GO:0048593]; cell chemotaxis [GO:0060326]; cell-substrate adhesion [GO:0031589]; central nervous system projection neuron axonogenesis [GO:0021952]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; ephrin receptor signaling pathway [GO:0048013]; establishment of cell polarity [GO:0030010]; immunological synapse formation [GO:0001771]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008]; optic nerve morphogenesis [GO:0021631]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; regulation of neuron death [GO:1901214]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle satellite cell activation [GO:0014719],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:18034775}; Single-pass type I membrane protein {ECO:0000269|PubMed:18034775}. Early endosome membrane {ECO:0000269|PubMed:18034775}. Cell projection, dendrite {ECO:0000250|UniProtKB:Q8CBF3}.",Ephrin type-B receptor 1 (EC 2.7.10.1) (ELK) (EPH tyrosine kinase 2) (EPH-like kinase 6) (EK6) (hEK6) (Neuronally-expressed EPH-related tyrosine kinase) (NET) (Tyrosine-protein kinase receptor EPH-2),GO:0001525; GO:0001771; GO:0004713; GO:0005005; GO:0005524; GO:0005576; GO:0005783; GO:0005829; GO:0005886; GO:0005887; GO:0007411; GO:0008046; GO:0014719; GO:0021631; GO:0021952; GO:0022008; GO:0030010; GO:0030424; GO:0030425; GO:0031290; GO:0031589; GO:0031901; GO:0032433; GO:0044877; GO:0045121; GO:0046328; GO:0046777; GO:0048013; GO:0048593; GO:0050965; GO:0051965; GO:0060326; GO:0060996; GO:0060997; GO:0061351; GO:0070062; GO:0070372; GO:1901214; GO:1902723; GO:1902725,0.791340913,0.750501098,0.665535967,0.950119419,1.00E-07,1.00E-07,0.212616528,0.000157055,0.972566012,0.808029552,0.000157055,-0.620517371,0.547326645,-3.271052684,0.010497406,0.022519493,-4.654959916,"109,885",1.647441401,5,0,2,,,1
P51674,GPM6A,GPM6A_HUMAN,axonal growth cone [GO:0044295]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; filopodium [GO:0030175]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; neural retina development [GO:0003407]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; positive regulation of filopodium assembly [GO:0051491]; stem cell differentiation [GO:0048863]; synapse assembly [GO:0007416],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Cell projection, axon {ECO:0000250}. Cell projection, dendritic spine {ECO:0000250}. Cell projection, filopodium {ECO:0000250}. Note=Localizes to cholesterol-rich lipid rafts of the plasma membrane of hippocampal neurons. Localized to plasma membrane of cell bodies and neurites of hippocampal neurons. Localized in membrane protrusions (filopodia and spines) of primary hippocampal neurons. Localized to the growth cone edge membrane of elongating axons (By similarity). {ECO:0000250}.",Neuronal membrane glycoprotein M6-a (M6a),GO:0001764; GO:0003407; GO:0005262; GO:0005886; GO:0007416; GO:0016021; GO:0030175; GO:0043005; GO:0043025; GO:0043197; GO:0044295; GO:0048812; GO:0048863; GO:0051491; GO:0070062; GO:1903561,0.155988028,0.18581291,0.055359688,0.168477478,0.317642839,0.2160773,0.230780611,0.244405471,0.171838888,0.048665362,0.230780611,0.162187591,0.155055226,3.269600871,0.010520962,0.022564792,-4.657303276,"31,210",1.646568667,3,2,0,,,1
Q14195,DPYSL3,DPYL3_HUMAN,"cell body [GO:0044297]; cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; extracellular space [GO:0005615]; filamentous actin [GO:0031941]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; chondroitin sulfate binding [GO:0035374]; filamin binding [GO:0031005]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; SH3 domain binding [GO:0017124]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; cellular response to cytokine stimulus [GO:0071345]; negative regulation of cell migration [GO:0030336]; negative regulation of neuron projection development [GO:0010977]; neuron development [GO:0048666]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of neuron projection development [GO:0010976]; protein homooligomerization [GO:0051260]; response to axon injury [GO:0048678]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell projection, growth cone {ECO:0000250}. Note=Colocalizes with synaptic vesicle protein 2 in the central region of the growth cone. {ECO:0000250}.",Dihydropyrimidinase-related protein 3 (DRP-3) (Collapsin response mediator protein 4) (CRMP-4) (Unc-33-like phosphoprotein 1) (ULIP-1),GO:0005615; GO:0005829; GO:0010976; GO:0010977; GO:0016810; GO:0017124; GO:0030027; GO:0030336; GO:0030426; GO:0031005; GO:0031941; GO:0035374; GO:0044297; GO:0048666; GO:0048678; GO:0051017; GO:0051260; GO:0051491; GO:0051764; GO:0070382; GO:0071345,1.00E-07,1.00E-07,1.00E-07,1.00E-07,0.007235822,0.007665237,1.00E-07,0.011302418,0.017115348,1.00E-07,0.007665237,0.008663685,0.004331943,3.071295082,0.014319602,0.029839765,-4.978354407,"61,963",1.525204596,31,5,1,,,1
Q9P2P1,NYNRIN,NYNRI_HUMAN,integral component of membrane [GO:0016021]; nucleic acid binding [GO:0003676]; DNA integration [GO:0015074],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.,Protein NYNRIN (NYN domain and retroviral integrase catalytic domain-containing protein) (Protein cousin of GIN1),GO:0003676; GO:0015074; GO:0016021,0.108262031,0.024563339,0.306138333,0.099522285,0.297640561,0.469876882,0.686368648,0.695980928,0.384194797,0.243731402,0.469876882,0.252528523,0.380548102,3.066679806,0.014423376,0.029988427,-4.985844636,"208,366",1.523046315,13,0,0,,1,1
O43157,PLXNB1,PLXB1_HUMAN,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; semaphorin receptor activity [GO:0017154]; semaphorin receptor binding [GO:0030215]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; axon extension [GO:0048675]; cell migration [GO:0016477]; G-protein coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of cell adhesion [GO:0007162]; negative regulation of osteoblast proliferation [GO:0033689]; neuron projection morphogenesis [GO:0048812]; ossification involved in bone maturation [GO:0043931]; positive regulation of axonogenesis [GO:0050772]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis [GO:1900220]; signal transduction [GO:0007165],SUBCELLULAR LOCATION: Isoform 1: Cell membrane; Single-pass type I membrane protein.; SUBCELLULAR LOCATION: Isoform 2: Secreted.; SUBCELLULAR LOCATION: Isoform 3: Secreted.,Plexin-B1 (Semaphorin receptor SEP),GO:0002116; GO:0004888; GO:0005096; GO:0005576; GO:0005622; GO:0005886; GO:0005887; GO:0007162; GO:0007165; GO:0007186; GO:0008360; GO:0014068; GO:0016477; GO:0017154; GO:0030215; GO:0032794; GO:0033689; GO:0035556; GO:0038023; GO:0043087; GO:0043547; GO:0043931; GO:0048675; GO:0048812; GO:0050772; GO:0051493; GO:0071526; GO:1900220,1.00E-07,1.00E-07,1.00E-07,1.00E-07,1.00E-07,0.027402243,0.033024139,0.026615869,0.00788033,1.00E-07,0.026615869,0.018984436,0.009492318,3.046408006,0.014888513,0.030858371,-5.018751085,"232,298",1.510627,32,5,1,,,1
Q7Z3G6,PRICKLE2,PRIC2_HUMAN,"cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; zinc ion binding [GO:0008270]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",SUBCELLULAR LOCATION: Nucleus membrane {ECO:0000305}.,Prickle-like protein 2,GO:0005737; GO:0008270; GO:0031965; GO:0060071,0.861779522,0.871469875,0.995818259,1.566552096,0.980882069,0.191148826,1.00E-07,1.00E-07,1.00E-07,0.782556569,1.00E-07,-0.565020539,0.516916508,-2.977221051,0.016596534,0.034054938,-5.131128325,"95,615",1.467819903,4,0,3,,,1
P16157,ANK1,ANK1_HUMAN,axolemma [GO:0030673]; basolateral plasma membrane [GO:0016323]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; ER to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165],"SUBCELLULAR LOCATION: Isoform Er1: Cytoplasm, cytoskeleton. Note=Probably the other erythrocyte (Er) isoforms, are located near the surface of erythrocytic plasma membrane.; SUBCELLULAR LOCATION: Isoform Mu17: Membrane. Cytoplasm, myofibril, sarcomere, M line. Note=Colocalizes with OBSCN isoform 3/obscurin at the M line in differentiated skeletal muscle cells.; SUBCELLULAR LOCATION: Isoform Mu18: Sarcoplasmic reticulum {ECO:0000305}.; SUBCELLULAR LOCATION: Isoform Mu19: Sarcoplasmic reticulum {ECO:0000305}.; SUBCELLULAR LOCATION: Isoform Mu20: Sarcoplasmic reticulum {ECO:0000305}.",Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin),GO:0005198; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0010638; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0045199; GO:0045211; GO:0051117; GO:0072659,1.00E-07,0.039021535,1.00E-07,0.108692422,0.314780841,0.40723948,0.141596609,0.168077256,0.575765291,1.00E-07,0.314780841,0.247025242,0.197979274,2.758900182,0.023437838,0.046286158,-5.485847068,"206,265",1.334548862,23,3,0,,,1
Q9Y2G0,EFR3B,EFR3B_HUMAN,cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphatidylinositol phosphorylation [GO:0046854]; protein localization to plasma membrane [GO:0072659],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:23229899, ECO:0000269|PubMed:25380825}; Lipid-anchor {ECO:0000269|PubMed:23229899, ECO:0000269|PubMed:25380825}. Cytoplasm, cytosol {ECO:0000269|PubMed:25380825}. Note=Palmitoylation anchors the protein to the plasma membrane (PubMed:23229899, PubMed:25380825). A small amount is observed in the cytosol (PubMed:25380825). {ECO:0000269|PubMed:23229899, ECO:0000269|PubMed:25380825}.",Protein EFR3 homolog B,GO:0005829; GO:0005886; GO:0046854; GO:0072659,0.169183555,0.085636379,0.095440979,0.103323311,0.027019612,0.047479348,0.088935122,0.076493959,0.140989726,0.174005295,0.076493959,-0.163924915,0.158146011,-2.665229739,0.027203765,0.053019817,-5.637715047,"92,487",1.275561775,16,0,0,,,1
Q8TC26,TMEM163,TM163_HUMAN,cell junction [GO:0030054]; early endosome membrane [GO:0031901]; integral component of synaptic vesicle membrane [GO:0030285]; zinc ion binding [GO:0008270],"SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Early endosome membrane {ECO:0000250}. Note=Glutamatergic synaptic vesicles. {ECO:0000250}.",Transmembrane protein 163,GO:0008270; GO:0030054; GO:0030285; GO:0031901,1.00E-07,1.00E-07,1.00E-07,0.194876398,1.00E-07,0.29480001,1.00E-07,1.00E-07,1.00E-07,0.413514604,1.00E-07,-0.372343235,0.245131699,-2.571426346,0.031593541,0.060793731,-5.789333368,"31,469",1.216141204,3,0,4,,1,1
Q684P5,RAP1GAP2,RPGP2_HUMAN,centrosome [GO:0005813]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; negative regulation of neuron projection development [GO:0010977]; regulation of cell size [GO:0008361]; regulation of small GTPase mediated signal transduction [GO:0051056],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15632203}. Cytoplasm, perinuclear region {ECO:0000269|PubMed:15632203}.",Rap1 GTPase-activating protein 2 (Rap1GAP2) (GTPase-activating Rap/Ran-GAP domain-like protein 4),GO:0005096; GO:0005813; GO:0005829; GO:0005886; GO:0008361; GO:0010977; GO:0031965; GO:0043005; GO:0048471; GO:0051056,0.112147945,0.018696366,0.117512344,0.072287888,0.232972595,0.277135774,0.211076986,0.251373526,0.156278657,0.304318647,0.232972595,-0.065886838,0.258710926,-2.484108585,0.036322389,0.06886135,-5.929865423,"80,056",1.162024465,15,0,0,,1,1
Q9UQB3,CTNND2,CTND2_HUMAN,"adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; beta-catenin binding [GO:0008013]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; transcription, DNA-templated [GO:0006351]; Wnt signaling pathway [GO:0016055]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O35927}. Cell junction, adherens junction {ECO:0000250|UniProtKB:O35927}. Cell projection, dendrite {ECO:0000250|UniProtKB:O35116}. Perikaryon {ECO:0000269|PubMed:22022388}.",Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein) (NPRAP) (Neurojungin),GO:0005634; GO:0005737; GO:0005912; GO:0006351; GO:0006355; GO:0007155; GO:0007165; GO:0008013; GO:0016055; GO:0030425; GO:0043204; GO:0050808; GO:0060828; GO:0060997; GO:0098609,0.353283634,0.319562568,0.397071984,0.187831027,0.488883167,0.71903049,0.54414585,1.213332903,0.345036582,0.285937251,0.54414585,0.35122234,0.486474628,2.340931847,0.045663676,0.084797419,-6.158539267,"132,656",1.071617368,28,0,0,,,1
O95757,HSPA4L,HS74L_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein folding [GO:0006457]; response to unfolded protein [GO:0006986],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}. Note=May translocate to the nucleus after heat shock. {ECO:0000250}.,Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94),GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986,0.073465515,0.10676331,0.100111586,0.085096386,0.079586326,0.041431234,0.021126784,0.023791125,0.018934559,1.00E-07,0.023791125,0.02915536,0.022396326,2.169884471,0.059995124,0.108068365,-6.427737664,"94,512",0.966301419,26,4,0,,,1
O94875,SORBS2,SRBS2_HUMAN,actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; cytoskeletal adaptor activity [GO:0008093]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049],"SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000269|PubMed:16125169, ECO:0000269|PubMed:9211900}. Apical cell membrane {ECO:0000269|PubMed:18559503}. Cell junction, focal adhesion {ECO:0000269|PubMed:18559503}. Cell projection, lamellipodium {ECO:0000269|PubMed:18559503}. Note=Found at the Z-disk sarcomeres, stress fibers, dense bodies and focal adhesion. In pancreatic acinar cells, localized preferentially to the apical membrane. Colocalized with vinculin and filamentous actin at focal adhesions and lamellipodia of pancreatic cells. {ECO:0000269|PubMed:18559503}.",Sorbin and SH3 domain-containing protein 2 (Arg-binding protein 2) (ArgBP2) (Arg/Abl-interacting protein 2) (Sorbin),GO:0003723; GO:0005200; GO:0005634; GO:0005654; GO:0005925; GO:0007015; GO:0008093; GO:0008307; GO:0015629; GO:0016324; GO:0030018; GO:0030027; GO:0048471; GO:0061049,0.016170638,0.01102016,1.00E-07,0.009760176,1.00E-07,0.003093857,1.00E-07,0.007516536,0.008732403,1.00E-07,0.003093857,0.003868499,0.00193435,1.997157533,0.078910069,0.137868952,-6.693483283,"124,108",0.860533525,28,5,2,,,1
Q01538,MYT1,MYT1_HUMAN,"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",SUBCELLULAR LOCATION: Nucleus.,Myelin transcription factor 1 (MyT1) (Myelin transcription factor I) (MyTI) (PLPB1) (Proteolipid protein-binding protein),GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0006355; GO:0007399; GO:0008270; GO:0030154,0.947479591,1.083219453,0.550223439,0.342971636,1.00E-07,1.00E-07,1.00E-07,1.00E-07,1.00E-07,0.059588096,1.00E-07,-0.086060837,0.043030518,-1.992474107,0.079495879,0.138761355,-6.700585045,"122,329",0.857731468,8,2,5,,,1
Q86UL8,MAGI2,MAGI2_HUMAN,bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; late endosome [GO:0005770]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; synapse [GO:0045202]; beta-1 adrenergic receptor binding [GO:0031697]; phosphatase binding [GO:0019902]; receptor signaling complex scaffold activity [GO:0030159]; SMAD binding [GO:0046332]; type II activin receptor binding [GO:0070699]; cellular response to nerve growth factor stimulus [GO:1990090]; glomerular visceral epithelial cell development [GO:0072015]; mitotic cell cycle arrest [GO:0071850]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of protein kinase B signaling [GO:0051898]; nerve growth factor signaling pathway [GO:0038180]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; planar cell polarity pathway involved in axis elongation [GO:0003402]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of receptor internalization [GO:0002092]; positive regulation of synaptic vesicle clustering [GO:2000809]; protein heterooligomerization [GO:0051291]; receptor clustering [GO:0043113]; SMAD protein signal transduction [GO:0060395],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Late endosome {ECO:0000250}. Cell junction, synapse, synaptosome {ECO:0000250}. Cell membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Note=Localized diffusely in the cytoplasm before nerve growth factor (NGF) stimulation. Recruted to late endosomes after NGF stimulation. Membrane-associated in synaptosomes (By similarity). {ECO:0000250}.","Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 (Atrophin-1-interacting protein 1) (AIP-1) (Atrophin-1-interacting protein A) (Membrane-associated guanylate kinase inverted 2) (MAGI-2)",GO:0002092; GO:0003402; GO:0005634; GO:0005737; GO:0005770; GO:0005886; GO:0005923; GO:0008285; GO:0010976; GO:0014069; GO:0019902; GO:0030159; GO:0030336; GO:0030425; GO:0031697; GO:0032516; GO:0032926; GO:0032991; GO:0036057; GO:0038180; GO:0043113; GO:0045202; GO:0046332; GO:0048471; GO:0051291; GO:0051898; GO:0060395; GO:0070699; GO:0071850; GO:0072015; GO:0097118; GO:1990090; GO:2000809,0.520217867,0.455988376,0.422646249,0.599702935,1.00E-07,1.00E-07,1.00E-07,1.00E-07,1.00E-07,0.031572019,1.00E-07,-0.07573593,0.037868065,-1.897932954,0.092250611,0.158187898,-6.842595063,"158,754",0.800826745,6,2,5,,,1
Q8WXI2,CNKSR2,CNKR2_HUMAN,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; identical protein binding [GO:0042802]; regulation of signal transduction [GO:0009966],SUBCELLULAR LOCATION: Cytoplasm. Membrane; Peripheral membrane protein.,Connector enhancer of kinase suppressor of ras 2 (Connector enhancer of KSR 2) (CNK homolog protein 2) (CNK2),GO:0005737; GO:0009966; GO:0014069; GO:0042802; GO:0043005; GO:0043025; GO:0045211; GO:0070062,1.00E-07,0.049243731,1.00E-07,1.00E-07,1.00E-07,1.00E-07,0.151177214,0.000229318,1.00E-07,0.156027512,1.00E-07,-0.116205342,0.088384037,-1.890238815,0.093370286,0.15998919,-6.854033267,"117,535",0.795909361,6,0,3,,1,1
Q04727,TLE4,TLE4_HUMAN,"beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding [GO:0003705]; beta-catenin-TCF complex assembly [GO:1904837]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of transcription by RNA polymerase II [GO:0000122]; transcription, DNA-templated [GO:0006351]; Wnt signaling pathway [GO:0016055]",SUBCELLULAR LOCATION: Nucleus.,Transducin-like enhancer protein 4 (Grg-4) (Groucho-related protein 4),GO:0000122; GO:0003682; GO:0003705; GO:0003714; GO:0005634; GO:0005654; GO:0006351; GO:0016055; GO:0070491; GO:1904837; GO:1990830; GO:1990907,0.3082708,0.315070967,0.313211126,0.240557586,0.502064631,0.719828582,0.58447917,0.609619719,0.738833981,0.537755214,0.609619719,0.1216042,0.570163117,1.783217469,0.110336905,0.184613648,-7.011081505,"83,755",0.733736195,5,0,0,,,1
Q9BXA9,SALL3,SALL3_HUMAN,"nucleus [GO:0005634]; DNA binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; forelimb morphogenesis [GO:0035136]; hindlimb morphogenesis [GO:0035137]; negative regulation of smoothened signaling pathway [GO:0045879]; neurogenesis [GO:0022008]; olfactory bulb interneuron development [GO:0021891]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]",SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,Sal-like protein 3 (Zinc finger protein 796) (Zinc finger protein SALL3) (hSALL3),GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006366; GO:0007165; GO:0021891; GO:0022008; GO:0035136; GO:0035137; GO:0043565; GO:0044212; GO:0045879; GO:0046872,0.263285822,0.031686313,1.00E-07,1.00E-07,0.237976607,0.121042549,0.128615789,0.107948576,1.071862881,1.00E-07,0.128615789,0.318817276,0.174080642,1.759937359,0.114391755,0.19057048,-7.044704814,"135,346",0.719944372,5,3,0,,,1
O14994,SYN3,SYN3_HUMAN,"cell junction [GO:0030054]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; ATP binding [GO:0005524]; neurotransmitter secretion [GO:0007269]; regulation of synaptic transmission, GABAergic [GO:0032228]","SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane; Peripheral membrane protein; Cytoplasmic side. Note=Peripheral membrane protein localized to the cytoplasmic surface of synaptic vesicles.",Synapsin-3 (Synapsin III),GO:0005524; GO:0007269; GO:0008021; GO:0014069; GO:0030054; GO:0030672; GO:0032228,0.099553801,0.087970568,0.086113065,0.012500983,1.00E-07,1.00E-07,1.00E-07,1.00E-07,1.00E-07,0.022647525,1.00E-07,-0.063124881,0.03156254,-1.753987508,0.115450118,0.192156894,-7.053265377,"63,303",0.716344029,5,0,5,,,1
Q9NSC5,HOMER3,HOME3_HUMAN,basal part of cell [GO:0045178]; cell junction [GO:0030054]; cytosol [GO:0005829]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; G-protein coupled glutamate receptor binding [GO:0035256]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; G-protein coupled glutamate receptor signaling pathway [GO:0007216]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of interleukin-2 production [GO:0032703]; protein targeting [GO:0006605],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell junction, synapse, postsynaptic cell membrane, postsynaptic density {ECO:0000250}. Cell junction, synapse {ECO:0000250}. Note=Postsynaptic density of neuronal cells. {ECO:0000250}.",Homer protein homolog 3 (Homer-3),GO:0005829; GO:0006605; GO:0007216; GO:0008022; GO:0014069; GO:0019904; GO:0030054; GO:0032703; GO:0035256; GO:0042802; GO:0045178; GO:0045211; GO:0070885,0.374186342,0.127141545,0.426905894,0.244058597,0.708471104,1.621184746,0.412899756,2.683412065,0.394523446,0.431766309,0.708471104,0.753491782,0.787352332,1.750506381,0.116073557,0.193128687,-7.058267704,"39,836",0.714153213,7,0,0,,1,1
Q8WUY1,THEM6,THEM6_HUMAN,extracellular region [GO:0005576],SUBCELLULAR LOCATION: Secreted {ECO:0000305}.,Protein THEM6 (Mesenchymal stem cell protein DSCD75) (Thioesterase superfamily member 6),GO:0005576,0.027769902,0.005828472,0.088732729,0.016643452,0.056333309,0.060783212,0.03604545,0.213106981,0.032345682,0.012491037,0.056333309,0.056116932,0.051664461,1.667632612,0.13186761,0.216023655,-7.175935365,"23,865",0.66549869,8,0,0,,,1
Q92618,ZNF516,ZN516_HUMAN,"nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; DNA binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; multicellular organism development [GO:0007275]; positive regulation of transcription, DNA-templated [GO:0045893]; response to cold [GO:0009409]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]",SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q7TSH3}.,Zinc finger protein 516,GO:0000981; GO:0000987; GO:0003700; GO:0005634; GO:0006366; GO:0007165; GO:0007275; GO:0009409; GO:0033613; GO:0043565; GO:0044212; GO:0045893; GO:0046872; GO:0050873; GO:0060612,0.727091254,0.868541121,0.700499948,0.786230652,0.699854717,1.625644748,0.84626391,0.801278345,0.640895495,0.587507927,0.801278345,0.295360523,0.775107181,1.649565655,0.135563189,0.22055556,-7.201209901,"124,289",0.656481989,11,0,0,,,1
Q9H4W6,EBF3,COE3_HUMAN,"nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0001077]; multicellular organism development [GO:0007275]; positive regulation of transcription, DNA-templated [GO:0045893]",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:28017373}.,Transcription factor COE3 (Early B-cell factor 3) (EBF-3) (Olf-1/EBF-like 2) (O/E-2) (OE-2),GO:0000978; GO:0000981; GO:0001077; GO:0005634; GO:0007275; GO:0045893; GO:0046872; GO:0046983,0.108996388,0.433156665,0.109058409,0.431265142,0.670688873,0.076837795,0.144601775,0.183675324,0.292893339,0.00870526,0.183675324,0.186926659,0.180276092,1.63984285,0.137590922,0.22314781,-7.214753045,"64,864",0.651407371,5,2,0,,,1
Q86VV8,RTTN,RTTN_HUMAN,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cilium organization [GO:0044782]; determination of left/right symmetry [GO:0007368],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, cilium basal body {ECO:0000269|PubMed:22939636}. Note=Colocalizes with the basal bodies at the primary cilium.",Rotatin,GO:0005737; GO:0005813; GO:0007368; GO:0036064; GO:0044782,1.00E-07,1.00E-07,1.00E-07,1.00E-07,0.069617092,0.005306324,0.004425169,0.010200943,0.004710687,1.00E-07,0.005306324,0.018851943,0.009426071,1.51995579,0.164954013,0.25950074,-7.378189652,"248,630",0.5858614,16,5,0,,,1
O15347,HMGB3,HMGB3_HUMAN,"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; RNA binding [GO:0003723]; DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P40618, ECO:0000255|PROSITE-ProRule:PRU00267}. Chromosome {ECO:0000305}. Cytoplasm {ECO:0000250|UniProtKB:O54879}.",High mobility group protein B3 (High mobility group protein 2a) (HMG-2a) (High mobility group protein 4) (HMG-4),GO:0000400; GO:0003690; GO:0003723; GO:0005634; GO:0005694; GO:0005737; GO:0006310; GO:0006351; GO:0006355; GO:0007275; GO:0008301; GO:0032392; GO:0045087,0.061341208,0.063041395,0.066101787,0.053021923,0.056042829,0.069870344,0.056881401,0.071005094,0.063113808,0.058731496,0.063113808,0.007587678,0.059588856,1.455104097,0.181698514,0.280324455,-7.463653528,"22,980",0.552339014,10,0,0,,,1
Q7L945,ZNF627,ZN627_HUMAN,"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcription, DNA-templated [GO:0006351]",SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,Zinc finger protein 627,GO:0000981; GO:0003677; GO:0005634; GO:0006351; GO:0046872,0.565832824,0.600403987,0.307272885,1.333075396,0.373273487,0.320335727,0.42917487,0.471128597,0.19162388,0.565019152,0.373273487,-0.269864157,0.492039391,-1.427586313,0.189244058,0.290222352,-7.499244671,"52,853",0.537269143,4,0,0,,,1
O95948,ONECUT2,ONEC2_HUMAN,"actin cytoskeleton [GO:0015629]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0001077]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cilium assembly [GO:0060271]; endocrine pancreas development [GO:0031018]; epithelial cell development [GO:0002064]; liver development [GO:0001889]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peripheral nervous system neuron development [GO:0048935]; positive regulation of cell migration [GO:0030335]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell-matrix adhesion [GO:0001952]",SUBCELLULAR LOCATION: Nucleus.,One cut domain family member 2 (Hepatocyte nuclear factor 6-beta) (HNF-6-beta) (One cut homeobox 2) (Transcription factor ONECUT-2) (OC-2),GO:0000978; GO:0000981; GO:0001077; GO:0001889; GO:0001952; GO:0002064; GO:0005634; GO:0005654; GO:0009887; GO:0015629; GO:0030154; GO:0030335; GO:0030512; GO:0031018; GO:0045165; GO:0045944; GO:0048935; GO:0060271,0.088690892,0.223426265,0.237165655,0.308452905,1.00E-07,1.00E-07,1.00E-07,1.00E-07,1.00E-07,0.019898291,1.00E-07,-0.064327152,0.032163676,-1.262872502,0.240311193,0.354995572,-7.703162217,"54,303",0.449777063,6,2,5,,,1
Q96PU5,NEDD4L,NED4L_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; intracellular [GO:0005622]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; ion channel binding [GO:0044325]; potassium channel inhibitor activity [GO:0019870]; potassium channel regulator activity [GO:0015459]; sodium channel inhibitor activity [GO:0019871]; sodium channel regulator activity [GO:0017080]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular sodium ion homeostasis [GO:0006883]; excretion [GO:0007588]; ion transmembrane transport [GO:0034220]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of sodium ion transmembrane transport [GO:1902306]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendrite extension [GO:1903861]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of membrane repolarization [GO:0060306]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; regulation of protein catabolic process [GO:0042176]; regulation of protein stability [GO:0031647]; response to metal ion [GO:0010038]; sodium ion transport [GO:0006814]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular cardiac muscle cell action potential [GO:0086005]; viral life cycle [GO:0019058]; water homeostasis [GO:0030104],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15496141, ECO:0000269|PubMed:18819914, ECO:0000269|PubMed:27694961}. Golgi apparatus {ECO:0000269|PubMed:26363003}. Endosome, multivesicular body {ECO:0000269|PubMed:26363003}. Note=May be recruited to exosomes by NDFIP1.",E3 ubiquitin-protein ligase NEDD4-like (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NED4L) (NEDD4.2) (Nedd4-2),GO:0000122; GO:0000209; GO:0003254; GO:0004842; GO:0005622; GO:0005654; GO:0005737; GO:0005771; GO:0005794; GO:0005829; GO:0006511; GO:0006513; GO:0006814; GO:0006883; GO:0007588; GO:0010038; GO:0015459; GO:0016567; GO:0017080; GO:0019058; GO:0019870; GO:0019871; GO:0030104; GO:0031647; GO:0034220; GO:0034765; GO:0042176; GO:0042391; GO:0043161; GO:0044325; GO:0045732; GO:0045807; GO:0060306; GO:0061630; GO:0070062; GO:0070936; GO:0086005; GO:1901016; GO:1901017; GO:1901380; GO:1902306; GO:1903861; GO:2000009; GO:2000650; GO:2001288,1.00E-07,1.00E-07,1.00E-07,0.003899679,1.00E-07,1.00E-07,1.00E-07,0.003447657,0.003983056,0.003658591,1.00E-07,-0.012355102,0.007663754,-1.199695038,0.262757601,0.383255526,-7.776889718,"111,932",0.416511575,23,2,3,,,1
O75923,DYSF,DYSF_HUMAN,cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; late endosome [GO:0005770]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phospholipid binding [GO:0005543]; muscle contraction [GO:0006936]; plasma membrane repair [GO:0001778]; vesicle fusion [GO:0006906],"SUBCELLULAR LOCATION: Cell membrane, sarcolemma; Single-pass type II membrane protein. Cytoplasmic vesicle membrane {ECO:0000250}; Single-pass type II membrane protein {ECO:0000250}. Cell membrane. Note=Colocalizes, during muscle differentiation, with BIN1 in the T-tubule system of myotubules and at the site of contact between two myotubes or a myoblast and a myotube. Wounding of myotubes led to its focal enrichment to the site of injury and to its relocalization in a Ca(2+)-dependent manner toward the plasma membrane. Colocalizes with AHNAK, AHNAK2 and PARVB at the sarcolemma of skeletal muscle. Detected on the apical plasma membrane of the syncytiotrophoblast. Reaches the plasmma membrane through a caveolin-independent mechanism. Retained by caveolin at the plasmma membrane (By similarity). Colocalizes, during muscle differentiation, with CACNA1S in the T-tubule system of myotubules (By similarity). Accumulates and colocalizes with fusion vesicles at the sarcolemma disruption sites (By similarity). {ECO:0000250}.",Dysferlin (Dystrophy-associated fer-1-like protein) (Fer-1-like protein 1),GO:0001778; GO:0005509; GO:0005543; GO:0005544; GO:0005768; GO:0005769; GO:0005770; GO:0005815; GO:0005886; GO:0006906; GO:0006936; GO:0016021; GO:0030027; GO:0030139; GO:0030315; GO:0030659; GO:0042383; GO:0070062,0.083780836,0.357423399,0.083871055,0.699543463,1.00E-07,0.052011362,0.004446494,0.000968801,1.00E-07,1.00E-07,0.000968801,0.011485271,0.005742736,1.158975077,0.278114701,0.402291697,-7.822985322,"237,295",0.395458931,12,5,2,,,1
Q99836,MYD88,MYD88_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; TIR domain binding [GO:0070976]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; cellular response to mechanical stimulus [GO:0071260]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of type I interferon production [GO:0032481]; regulation of inflammatory response [GO:0050727]; response to interleukin-1 [GO:0070555]; signal transduction [GO:0007165]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224]; type I interferon signaling pathway [GO:0060337],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15361868, ECO:0000269|PubMed:15492225}. Nucleus {ECO:0000269|PubMed:21057262}.",Myeloid differentiation primary response protein MyD88,GO:0002224; GO:0002755; GO:0005123; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0006954; GO:0007165; GO:0007166; GO:0010008; GO:0010628; GO:0032481; GO:0032740; GO:0032747; GO:0032755; GO:0034162; GO:0042802; GO:0043066; GO:0043123; GO:0043621; GO:0050727; GO:0050830; GO:0051092; GO:0060337; GO:0070498; GO:0070555; GO:0070935; GO:0070976; GO:0071260; GO:0140052; GO:1900017,0.058629428,0.011992367,1.00E-07,0.022680775,0.138779995,0.211874449,0.053660408,0.164354747,0.07447961,0.077207732,0.138779995,0.042013349,0.107623167,1.102905293,0.300434464,0.429205355,-7.884549284,"33,233",0.367334868,12,0,0,,1,1
Q9BVV7,TIMM21,TIM21_HUMAN,integral component of membrane [GO:0016021]; mitochondrial inner membrane presequence translocase complex [GO:0005744]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex IV assembly [GO:0033617]; protein import into mitochondrial matrix [GO:0030150],SUBCELLULAR LOCATION: Mitochondrion membrane {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.,"Mitochondrial import inner membrane translocase subunit Tim21 (TIM21-like protein, mitochondrial)",GO:0005744; GO:0016021; GO:0030150; GO:0032981; GO:0033617,1.00E-07,1.00E-07,1.00E-07,1.00E-07,1.00E-07,1.00E-07,1.00E-07,1.00E-07,0.371189065,0.102141395,1.00E-07,-0.146901601,0.147688693,-1.080741178,0.309639149,0.43984077,-7.908256444,"28,202",0.356704517,3,0,4,,,1
Q8NFP4,MDGA1,MDGA1_HUMAN,anchored component of plasma membrane [GO:0046658]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; brain development [GO:0007420]; neuron migration [GO:0001764]; spinal cord association neuron differentiation [GO:0021527],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15922729}; Lipid-anchor, GPI-anchor {ECO:0000269|PubMed:15922729}. Note=Associated with lipid rafts.",MAM domain-containing glycosylphosphatidylinositol anchor protein 1 (GPI and MAM protein) (GPIM) (Glycosylphosphatidylinositol-MAM) (MAM domain-containing protein 3),GO:0001764; GO:0005576; GO:0005615; GO:0005886; GO:0007420; GO:0021527; GO:0046658,1.00E-07,1.00E-07,1.00E-07,1.00E-07,0.314080767,0.43857902,0.02741853,0.053650765,0.101798993,0.322955989,0.101798993,-0.616865493,0.495538361,-1.079060375,0.310346101,0.440672628,-7.910039434,"105,790",0.355883924,19,0,0,,,1
Q96KP4,CNDP2,CNDP2_HUMAN,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; glutathione biosynthetic process [GO:0006750],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12473676, ECO:0000269|PubMed:17121880}.",Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Carnosine dipeptidase II) (Epididymis secretory protein Li 13) (Glutamate carboxypeptidase-like protein 1) (Peptidase A),GO:0004180; GO:0005654; GO:0005829; GO:0006750; GO:0008237; GO:0046872; GO:0070062; GO:0102008; GO:0103046,0.035092978,0.023349677,0.02108596,0.03452653,0.010019808,0.020301973,0.016564324,0.026859073,0.032196403,0.02702207,0.020301973,-0.007210618,0.024793625,-1.022213926,0.335003264,0.440795537,-7.969086026,"52,878",0.355762812,30,0,0,,1,1
Q8NB78,KDM1B,KDM1B_HUMAN,"nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-monomethyl-K4 specific) [GO:0034649]; zinc ion binding [GO:0008270]; DNA methylation involved in gamete generation [GO:0043046]; histone H3-K4 demethylation [GO:0034720]; multicellular organism development [GO:0007275]; protein deubiquitination [GO:0016579]; regulation of DNA methylation [GO:0044030]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.,Lysine-specific histone demethylase 1B (EC 1.-.-.-) (Flavin-containing amine oxidase domain-containing protein 1) (Lysine-specific histone demethylase 2),GO:0000786; GO:0003677; GO:0005634; GO:0005654; GO:0006349; GO:0006351; GO:0006355; GO:0007275; GO:0008270; GO:0016579; GO:0032452; GO:0034648; GO:0034649; GO:0034720; GO:0042393; GO:0043046; GO:0044030; GO:0071949,0.117185778,0.132449033,0.18144981,0.068713926,0.042681734,0.160458008,0.030054645,1.819637828,0.026419854,0.522227893,0.042681734,-0.776157218,0.803929023,-1.021177149,0.335466529,0.441024246,-7.970139948,"92,098",0.355537533,14,0,0,,1,1
Q15818,NPTX1,NPTX1_HUMAN,transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; axonogenesis involved in innervation [GO:0060385]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268],"SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle {ECO:0000305}.",Neuronal pentraxin-1 (NP1) (Neuronal pentraxin I) (NP-I),GO:0007268; GO:0007417; GO:0030133; GO:0046872; GO:0060385,1.00E-07,1.00E-07,1.00E-07,0.12169066,0.240751855,0.288178928,0.072918044,0.099270913,0.193039289,0.203979407,0.193039289,-0.080576289,0.219119951,-1.020259681,0.33587689,0.441124677,-7.971071892,"47,122",0.355438647,5,0,0,,,1
Q9P206,KIAA1522,K1522_HUMAN,cell differentiation [GO:0030154],,Uncharacterized protein KIAA1522,GO:0030154,0.18184252,0.233989174,0.140577241,0.107280609,0.060287792,0.14773908,0.150239469,0.081510396,0.229026187,0.166603602,0.14773908,-0.030301288,0.148911229,-0.976399545,0.355942331,0.457534102,-8.014853202,"107,095",0.339576531,12,0,0,,,1
Q13485,SMAD4,SMAD4_HUMAN,"activin responsive factor complex [GO:0032444]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; collagen binding [GO:0005518]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; proximal promoter sequence-specific DNA binding [GO:0000987]; R-SMAD binding [GO:0070412]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; RNA polymerase II transcription factor binding [GO:0001085]; sulfate binding [GO:0043199]; transcription regulatory region DNA binding [GO:0044212]; transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0001077]; transforming growth factor beta receptor, common-partner cytoplasmic mediator activity [GO:0030616]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; cellular response to BMP stimulus [GO:0071773]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endoderm development [GO:0007492]; endothelial cell activation [GO:0042118]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation with mouth forming second [GO:0001702]; in utero embryonic development [GO:0001701]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; mesoderm development [GO:0007498]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate commitment [GO:0048663]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; protein deubiquitination [GO:0016579]; protein homotrimerization [GO:0070207]; regulation of binding [GO:0051098]; regulation of hair follicle development [GO:0051797]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to transforming growth factor beta [GO:0071559]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somatic stem cell population maintenance [GO:0035019]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15799969, ECO:0000269|PubMed:17327236}. Nucleus {ECO:0000269|PubMed:15799969}. Note=Cytoplasmic in the absence of ligand. Migrates to the nucleus when complexed with R-SMAD (PubMed:15799969). PDPK1 prevents its nuclear translocation in response to TGF-beta (PubMed:17327236). {ECO:0000269|PubMed:15799969, ECO:0000269|PubMed:17327236}.",Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4) (SMAD family member 4) (SMAD 4) (Smad4) (hSMAD4),GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0000987; GO:0001077; GO:0001085; GO:0001541; GO:0001658; GO:0001666; GO:0001701; GO:0001702; GO:0003148; GO:0003190; GO:0003198; GO:0003220; GO:0003251; GO:0003360; GO:0003682; GO:0005518; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0005829; GO:0006879; GO:0007179; GO:0007183; GO:0007283; GO:0007338; GO:0007411; GO:0007492; GO:0007498; GO:0008283; GO:0008285; GO:0010614; GO:0010718; GO:0010862; GO:0014033; GO:0016579; GO:0017015; GO:0030308; GO:0030509; GO:0030511; GO:0030513; GO:0030616; GO:0032444; GO:0032525; GO:0032909; GO:0033686; GO:0035019; GO:0035556; GO:0036302; GO:0042118; GO:0042733; GO:0042802; GO:0042803; GO:0043199; GO:0044212; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0046881; GO:0046982; GO:0048589; GO:0048663; GO:0048733; GO:0048859; GO:0051098; GO:0051571; GO:0051797; GO:0060065; GO:0060391; GO:0060395; GO:0060412; GO:0060548; GO:0060956; GO:0061040; GO:0061614; GO:0062009; GO:0070102; GO:0070207; GO:0070373; GO:0070411; GO:0070412; GO:0071141; GO:0071559; GO:0071773; GO:0072133; GO:0072134; GO:0072520; GO:1901522; GO:1905305; GO:2000617,0.192362186,0.032872252,0.149498721,0.091748391,0.142774832,0.009389758,0.02217534,0.024242425,0.087496599,0.087159495,0.024242425,-0.038533567,0.076482574,-0.931442353,0.377425299,0.480472851,-8.058129942,"60,439",0.318331147,11,1,0,,,1
Q96RG2,PASK,PASK_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]; energy homeostasis [GO:0097009]; negative regulation of glycogen biosynthetic process [GO:0045719]; positive regulation of translation [GO:0045727]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of glucagon secretion [GO:0070092]; regulation of respiratory gaseous exchange [GO:0043576],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17595531}. Nucleus {ECO:0000269|PubMed:17595531}. Note=Localizes in the nucleus of testis germ cells and in the midpiece of sperm tails.,PAS domain-containing serine/threonine-protein kinase (PAS-kinase) (PASKIN) (hPASK) (EC 2.7.11.1),GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0035091; GO:0043576; GO:0045719; GO:0045727; GO:0046777; GO:0070092; GO:0097009,0.03932577,0.009701385,0.006539027,0.022738733,0.00181053,1.00E-07,1.00E-07,0.014011107,0.001652189,1.00E-07,0.001652189,-0.007714208,0.007351909,-0.907945706,0.389023871,0.492795549,-8.080087763,"142,929",0.307333223,18,3,2,,,1
Q8N4Q0,ZADH2,PTGR3_HUMAN,peroxisome [GO:0005777]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; zinc ion binding [GO:0008270]; negative regulation of fat cell differentiation [GO:0045599],SUBCELLULAR LOCATION: Peroxisome {ECO:0000250|UniProtKB:Q8BGC4}.,Prostaglandin reductase 3 (PRG-3) (EC 1.3.1.48) (Zinc-binding alcohol dehydrogenase domain-containing protein 2),GO:0005777; GO:0008270; GO:0036132; GO:0045599; GO:0047522,1.00E-07,0.071660188,0.032237907,0.019879638,0.05699868,0.001038197,0.020058547,0.016047442,0.02644445,1.00E-07,0.020058547,0.012512306,0.01786131,0.903194499,0.391400169,0.495127372,-8.08447182,"40,140",0.305283064,4,3,0,,,1
O75037,KIF21B,KI21B_HUMAN,cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; growth cone [GO:0030426]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:Q9QXL1}. Cell projection, dendrite {ECO:0000250|UniProtKB:Q9QXL1}. Cell projection, growth cone {ECO:0000250|UniProtKB:Q9QXL1}. Cell projection, axon {ECO:0000250|UniProtKB:Q9QXL1}. Cytoplasmic vesicle {ECO:0000250|UniProtKB:F1M5N7}.",Kinesin-like protein KIF21B,GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0030425; GO:0030426; GO:0031410,0.263372222,0.137642102,0.038684332,0.118325438,1.00E-07,1.00E-07,1.00E-07,0.000181024,0.112476692,0.054807848,1.00E-07,-0.022948519,0.034005863,-0.845901603,0.420875246,0.525653455,-8.135827944,"182,662",0.279300477,30,1,3,,,1
Q3B7J2,GFOD2,GFOD2_HUMAN,extracellular region [GO:0005576]; oxidoreductase activity [GO:0016491]; extracellular matrix organization [GO:0030198],"SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix {ECO:0000250}.",Glucose-fructose oxidoreductase domain-containing protein 2 (EC 1.-.-.-),GO:0005576; GO:0016491; GO:0030198,0.091960555,0.039151817,1.00E-07,0.042173383,0.161699603,0.068197883,2.783744644,0.058156721,0.110810904,0.205793687,0.110810904,0.427322636,0.422860633,0.817402296,0.436100069,0.54188701,-8.160316797,"42,255",0.26609126,5,0,0,,,1
Q9Y4F5,CEP170B,C170B_HUMAN,cytoplasm [GO:0005737]; microtubule [GO:0005874],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:Q498L0}.",Centrosomal protein of 170 kDa protein B (Centrosomal protein 170B) (Cep170B),GO:0005737; GO:0005874,0.129456903,0.171308325,0.17016386,0.182558634,0.306267325,0.338827437,0.328617638,0.1639473,0.158451711,0.276799298,0.306267325,-0.037244977,0.277844771,-0.811387064,0.439361126,0.545206411,-8.16539416,"171,688",0.263439046,17,0,0,,,1
Q6ICG6,KIAA0930,K0930_HUMAN,,,Uncharacterized protein KIAA0930,,0.15520543,0.210069914,0.065199882,0.262395114,0.225139634,0.389602259,0.280449446,0.150674286,0.295700722,0.329461038,0.280449446,-0.053693337,0.295159938,-0.749849697,0.473669052,0.582618605,-8.215473599,"45,794",0.234615651,8,0,0,,1,1
Q13796,SHROOM2,SHRM2_HUMAN,apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; ligand-gated sodium channel activity [GO:0015280]; apical protein localization [GO:0045176]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; camera-type eye morphogenesis [GO:0048593]; cell migration [GO:0016477]; cellular pigment accumulation [GO:0043482]; ear development [GO:0043583]; establishment of melanosome localization [GO:0032401]; eye pigment granule organization [GO:0008057]; lens morphogenesis in camera-type eye [GO:0002089]; melanosome organization [GO:0032438],"SUBCELLULAR LOCATION: Apical cell membrane {ECO:0000250}. Cell junction, tight junction {ECO:0000250}. Cytoplasm, cytoskeleton {ECO:0000250}. Note=Associates with cortical F-actin. {ECO:0000250}.",Protein Shroom2 (Apical-like protein) (Protein APXL),GO:0002089; GO:0003779; GO:0005737; GO:0005856; GO:0005874; GO:0005886; GO:0005913; GO:0005923; GO:0007420; GO:0008013; GO:0008057; GO:0015280; GO:0016324; GO:0016477; GO:0032401; GO:0032438; GO:0043010; GO:0043482; GO:0043583; GO:0045176; GO:0048593; GO:0051015; GO:0070062,0.059232501,0.043527513,0.035551352,0.037434076,0.030798612,0.011796113,0.043874822,0.023763502,0.041863651,0.019425982,0.030798612,0.007329913,0.026754384,0.690081776,0.508618113,0.619589337,-8.2607887,"176,410",0.207896065,42,1,0,,,1
Q9H6K5,PRR36,PRR36_HUMAN,,,Proline-rich protein 36,,0.065506497,0.087140371,0.068258448,0.134216198,0.048561966,0.10780528,0.139698773,0.034854775,0.029551743,0.084162095,0.048561966,-0.016414615,0.080301815,-0.625943885,0.547855062,0.660851676,-8.305658444,"132,748",0.179896004,8,0,0,,,1
Q7RTP6,MICAL3,MICA3_HUMAN,"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; actin filament depolymerization [GO:0030042]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887]; oxidation-reduction process [GO:0055114]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15694364}. Cytoplasm, cell cortex {ECO:0000269|PubMed:21596566}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:15694364}. Nucleus {ECO:0000269|PubMed:24440334}. Midbody {ECO:0000269|PubMed:27528609}. Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:27528609}. Cytoplasm, cytoskeleton, cilium basal body {ECO:0000305|PubMed:26485645}. Note=Mainly localizes in the nucleus. {ECO:0000269|PubMed:24440334}.",[F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3),GO:0003779; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005886; GO:0005938; GO:0006887; GO:0007010; GO:0007049; GO:0016709; GO:0030042; GO:0030496; GO:0042995; GO:0046872; GO:0051301; GO:0055114; GO:0071949,0.044982864,0.098918938,0.119638306,0.073207426,0.090865802,0.080404725,0.079496347,0.047689975,0.042281067,0.048906774,0.079496347,0.009082897,0.063606135,0.573532824,0.581198489,0.69527251,-8.339355972,"224,295",0.157844942,28,0,0,,,1
P24821,TNC,TENA_HUMAN,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; interstitial matrix [GO:0005614]; membrane [GO:0016020]; syndecan binding [GO:0045545]; bud outgrowth involved in lung branching [GO:0060447]; cell adhesion [GO:0007155]; cellular protein metabolic process [GO:0044267]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to retinoic acid [GO:0071300]; cellular response to vitamin D [GO:0071305]; extracellular matrix organization [GO:0030198]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; negative regulation of cell adhesion [GO:0007162]; neuromuscular junction development [GO:0007528]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; post-translational protein modification [GO:0043687]; prostate gland epithelium morphogenesis [GO:0060740]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; response to wounding [GO:0009611]; wound healing [GO:0042060],"SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix.",Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C),GO:0001649; GO:0005576; GO:0005604; GO:0005614; GO:0005615; GO:0005788; GO:0005925; GO:0007155; GO:0007162; GO:0007528; GO:0008284; GO:0009611; GO:0009612; GO:0010628; GO:0014012; GO:0016020; GO:0030198; GO:0031012; GO:0042060; GO:0042475; GO:0043687; GO:0044267; GO:0045471; GO:0045545; GO:0060447; GO:0060739; GO:0060740; GO:0062023; GO:0071300; GO:0071305; GO:0071774; GO:0071799,0.026425233,1.00E-07,1.00E-07,0.033689858,1.00E-07,1.00E-07,0.088258255,0.000193398,0.047930706,0.01670686,0.000193398,-0.013718698,0.034135861,-0.548995606,0.59718906,0.71108951,-8.354196031,"240,853",0.148075728,29,0,2,,1,1
P50749,RASSF2,RASF2_HUMAN,condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein kinase activity [GO:0004672]; bone remodeling [GO:0046849]; cell cycle [GO:0007049]; epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade [GO:0038168]; homeostasis of number of cells [GO:0048872]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; ossification [GO:0001503]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase activity [GO:0045860]; protein stabilization [GO:0050821]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoclast differentiation [GO:0045670]; skeletal system development [GO:0001501],"SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Chromosome, centromere, kinetochore {ECO:0000269|PubMed:20813266}. Note=Translocates to the cytoplasm in the presence of STK3/MST2 AND STK4/MST1.",Ras association domain-containing protein 2,GO:0000776; GO:0000777; GO:0001501; GO:0001503; GO:0004672; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007049; GO:0031954; GO:0032991; GO:0033137; GO:0038168; GO:0043065; GO:0045667; GO:0045670; GO:0045860; GO:0046330; GO:0046849; GO:0048872; GO:0050821; GO:1901223,0.106743141,0.023914954,0.184321185,0.098560538,0.090775279,0.157523499,0.129691879,0.153114235,0.070980328,0.133120289,0.129691879,0.014202365,0.113315861,0.529972145,0.609747931,0.72413601,-8.365285271,"37,790",0.140179855,11,0,0,,,1
Q8IVF2,AHNAK2,AHNK2_HUMAN,costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018],SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.,Protein AHNAK2,GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0030018; GO:0030315; GO:0030659; GO:0042383; GO:0043034,0.233111877,0.111009077,0.260039203,0.224657173,0.034440901,1.00E-07,0.16889914,0.000769669,1.00E-07,0.002615954,0.000769669,-0.025615936,0.05362995,-0.475935609,0.646162293,0.762237377,-8.394777828,"616,629",0.117909759,31,2,2,,,1
Q96K83,ZNF521,ZN521_HUMAN,"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; neuron fate commitment [GO:0048663]; transcription, DNA-templated [GO:0006351]",SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.,Zinc finger protein 521 (Early hematopoietic zinc finger protein) (LYST-interacting protein 3),GO:0000981; GO:0003677; GO:0005634; GO:0006351; GO:0019904; GO:0046872; GO:0048663,0.048403719,0.025927248,0.012219886,1.00E-07,0.148967228,0.00518535,1.00E-07,0.000574193,1.00E-07,1.00E-07,0.000574193,0.01379045,0.024050169,0.447455372,0.665776019,0.781883027,-8.409113207,"147,866",0.106858214,14,3,2,,,1
Q9UPA5,BSN,BSN_HUMAN,axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cytoskeleton of presynaptic active zone [GO:0048788]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; presynapse to nucleus signaling pathway [GO:0099526]; protein localization to synapse [GO:0035418]; synapse assembly [GO:0007416],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell junction, synapse, synaptosome {ECO:0000250}. Cytoplasm, cytoskeleton. Note=Localized to the active zone of presynaptic density. {ECO:0000250}.",Protein bassoon (Zinc finger protein 231),GO:0005634; GO:0007268; GO:0007416; GO:0009986; GO:0014069; GO:0030054; GO:0030424; GO:0030425; GO:0035418; GO:0044306; GO:0046872; GO:0048786; GO:0048788; GO:0060076; GO:0099526,0.554501992,0.575025021,0.571320079,0.388724389,0.020215918,0.095950777,0.015068282,0.169505289,0.077369233,1.00E-07,0.077369233,-0.031465926,0.091354863,-0.423841034,0.682247727,0.798691122,-8.420359165,"416,469",0.097621143,29,3,0,,,1
P26378,ELAVL4,ELAV4_HUMAN,AU-rich element binding [GO:0017091]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA processing [GO:0006396],,ELAV-like protein 4 (Hu-antigen D) (HuD) (Paraneoplastic encephalomyelitis antigen HuD),GO:0003723; GO:0003730; GO:0006396; GO:0006397; GO:0017091,0.279186091,0.047894425,0.077111234,0.08105353,0.468573984,0.040638993,0.084910116,0.055724649,0.217523984,0.055532124,0.084910116,0.015978823,0.165484934,0.145658135,0.887600435,0.999239452,-8.507858901,"41,770",0.000330427,3,1,0,,,1
Q9BYV9,BACH2,BACH2_HUMAN,"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding transcription factor activity [GO:0003700]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding [GO:0001206]; import into nucleus [GO:0051170]; protein ubiquitination [GO:0016567]; transcription by RNA polymerase II [GO:0006366]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17018862}. Nucleus {ECO:0000255|PROSITE-ProRule:PRU00978, ECO:0000269|PubMed:17018862}. Note=Nucleocytoplasmic shuttling is controlled by phosphorylation. {ECO:0000269|PubMed:17018862}.",Transcription regulator protein BACH2 (BTB and CNC homolog 2),GO:0000980; GO:0000981; GO:0001206; GO:0003700; GO:0005634; GO:0005829; GO:0006366; GO:0016567; GO:0031463; GO:0051170,0.157580787,1.00E-07,1.00E-07,1.00E-07,0.47921895,0.220713098,0.5024499,0.32362464,0.465839274,0.406312136,0.465839274,-0.01231809,0.404528218,-0.138019131,0.893452372,1,-8.50906706,"92,537",0,9,0,0,,,1
P49257,LMAN1,LMAN1_HUMAN,endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; host cell perinuclear region of cytoplasm [GO:0044220]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; sarcomere [GO:0030017]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; blood coagulation [GO:0007596]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; ER to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; negative regulation of protein targeting to mitochondrion [GO:1903215]; positive regulation of organelle organization [GO:0010638]; protein folding [GO:0006457]; protein transport [GO:0015031],SUBCELLULAR LOCATION: Endoplasmic reticulum-Golgi intermediate compartment membrane; Single-pass type I membrane protein. Golgi apparatus membrane; Single-pass membrane protein. Endoplasmic reticulum membrane; Single-pass type I membrane protein.,Protein ERGIC-53 (ER-Golgi intermediate compartment 53 kDa protein) (Gp58) (Intracellular mannose-specific lectin MR60) (Lectin mannose-binding 1),GO:0000139; GO:0005537; GO:0005789; GO:0005793; GO:0006457; GO:0006888; GO:0007029; GO:0007030; GO:0007596; GO:0010638; GO:0012507; GO:0015031; GO:0016020; GO:0016021; GO:0030017; GO:0033116; GO:0044220; GO:0046872; GO:0048208; GO:0051082; GO:0070062; GO:1903215,0.003663397,1.00E-07,0.009025567,0.004156347,1.00E-07,1.00E-07,0.01705512,0.006218394,0.032971047,0.013287706,0.006218394,-0.000721285,0.011609595,-0.098661778,0.92370344,1,-8.514263982,"57,549",0,23,1,2,,1,1
Q8WUI4,HDAC7,HDAC7_HUMAN,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 14-3-3 protein binding [GO:0071889]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; repressing transcription factor binding [GO:0070491]; SUMO transferase activity [GO:0019789]; transcription corepressor activity [GO:0003714]; cell-cell junction assembly [GO:0007043]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; transcription, DNA-templated [GO:0006351]; vasculogenesis [GO:0001570]","SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=In the nucleus, it associates with distinct subnuclear dot-like structures. Shuttles between the nucleus and the cytoplasm. Treatment with EDN1 results in shuttling from the nucleus to the perinuclear region. The export to cytoplasm depends on the interaction with the 14-3-3 protein YWHAE and is due to its phosphorylation.",Histone deacetylase 7 (HD7) (EC 3.5.1.98) (Histone deacetylase 7A) (HD7a),GO:0000118; GO:0000122; GO:0001570; GO:0003682; GO:0003714; GO:0005080; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006351; GO:0007043; GO:0019789; GO:0019901; GO:0032041; GO:0032703; GO:0033613; GO:0045668; GO:0046872; GO:0070491; GO:0071889; GO:0090050; GO:1901223,0.069930551,0.065561722,0.099541125,0.07698248,0.047854292,0.17753159,0.027669242,0.034642006,0.064280679,0.066144616,0.047854292,-0.002733349,0.071762236,-0.085190301,0.934090768,1,-8.51564673,"102,927",0,11,0,0,,,1
Q9Y3Q0,NAALAD2,NALD2_HUMAN,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; N-formylglutamate deformylase activity [GO:0050129]; serine-type peptidase activity [GO:0008236]; cellular amino acid biosynthetic process [GO:0008652]; neurotransmitter catabolic process [GO:0042135]; proteolysis [GO:0006508],SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q04609}; Single-pass type II membrane protein {ECO:0000250|UniProtKB:Q04609}.,N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II),GO:0004180; GO:0005886; GO:0006508; GO:0008236; GO:0008237; GO:0008239; GO:0008652; GO:0016021; GO:0016805; GO:0042135; GO:0046872; GO:0050129,1.00E-07,1.00E-07,1.00E-07,1.00E-07,0.018362416,0.117157788,1.00E-07,4.05E-05,1.00E-07,1.00E-07,4.05E-05,6.76E-05,0.027078381,0.001965309,0.998477443,1,-8.519698622,"83,592",0,8,4,2,,,1